Brand_name,Drug_name_original,Drug_name,Sponsor,DrugId,Properties,Indication,Indication_EFO,DiseaseId,TA,Review_type,Year,targetIds,has_GE
Lutathera,Lutetium Lu 177 dotatate,LUTETIUM LU 177 DOTATATE,Advanced Accelerator Applications/Novartis,CHEMBL3989924,Somatostatin receptor-targeted radiopharmaceutical,GEP-NETs,digestive system neuroendocrine neoplasm,MONDO_0024503,Oncology,"P, O",2018,"ENSG00000139874, ENSG00000162009, ENSG00000278195, ENSG00000132671, ENSG00000180616",TRUE
Biktarvy,Bictegravir; emtricitabine; tenofovir alafenamide,BICTEGRAVIR,Gilead Sciences,CHEMBL3989866,HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors,HIV,hiv infection,EFO_0000764,Infectious,P,2018,NA,NA
Biktarvy,Bictegravir; emtricitabine; tenofovir alafenamide,EMTRICITABINE,Gilead Sciences,CHEMBL885,HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors,HIV,hiv infection,EFO_0000764,Infectious,P,2018,NA,NA
Biktarvy,Bictegravir; emtricitabine; tenofovir alafenamide,TENOFOVIR ALAFENAMIDE,Gilead Sciences,CHEMBL2107825,HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors,HIV,hiv infection,EFO_0000764,Infectious,P,2018,NA,NA
Symdeko,Tezacaftor; ivacaftor,TEZACAFTOR,Vertex Pharmaceuticals,CHEMBL3544914,CFTR corrector and CFTR potentiator,Cystic fibrosis,cystic fibrosis,MONDO_0009061,Metabolic,"P, O, B",2018,ENSG00000001626,TRUE
Symdeko,Tezacaftor; ivacaftor,IVACAFTOR,Vertex Pharmaceuticals,CHEMBL2010601,CFTR corrector and CFTR potentiator,Cystic fibrosis,cystic fibrosis,MONDO_0009061,Metabolic,"P, O, B",2018,ENSG00000001626,TRUE
Erleada,Apalutamide,APALUTAMIDE,Johnson & Johnson,CHEMBL3183409,Androgen receptor inhibitor,Prostate cancer,prostate cancer,MONDO_0008315,Oncology,P,2018,ENSG00000169083,TRUE
Trogarzo,Ibalizumab,IBALIZUMAB,TaiMed Biologics/Theratechnologies,CHEMBL1743029,CD4 antibody,HIV,hiv infection,EFO_0000764,Infectious,"P, O, B",2018,ENSG00000010610,TRUE
Ilumya,Tildrakizumab,TILDRAKIZUMAB,Sun Pharma,CHEMBL2108681,IL-23 antibody,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,Dermatology,S,2018,"ENSG00000110944, ENSG00000113302",TRUE
Tavalisse,Fostamatinib,FOSTAMATINIB,Rigel Pharmaceuticals,CHEMBL2103830,SYK inhibitor,Immune thrombocytopenic purpura,autoimmune thrombocytopenic purpura,EFO_0007160,Hematology,"S, O",2018,ENSG00000165025,TRUE
Crysvita,Burosumab,BUROSUMAB,Ultragenyx Pharmaceutical/Kyowa Hakko Kirin,CHEMBL3707326,FGF23 antibody,X-linked hypophosphataemia,Hypophosphatemia,HP_0002148,Endocrine,"P, O, B",2018,ENSG00000118972,TRUE
Akynzeo IV,Palonosetron; fosnetupitant,PALONOSETRON,Helsinn Group,CHEMBL1189679,5-HT3-receptor antagonist and NK1-receptor antagonist,Chemotherapy-induced emesis,Chemotherapy-induced nausea and vomiting,EFO_0006911,Other,S,2018,ENSG00000166736,FALSE
Akynzeo IV,Palonosetron; fosnetupitant,FOSNETUPITANT,Helsinn Group,CHEMBL3989917,5-HT3-receptor antagonist and NK1-receptor antagonist,Chemotherapy-induced emesis,Chemotherapy-induced nausea and vomiting,EFO_0006911,Other,S,2018,ENSG00000115353,FALSE
Lucemyra,Lofexidine,LOFEXIDINE,US WorldMeds,CHEMBL17860,beta2-adrenoceptor agonist,Opioid withdrawal,opioid dependence,EFO_0005611,Other,P,2018,"ENSG00000150594, ENSG00000274286, ENSG00000184160",FALSE
Aimovig,Erenumab,ERENUMAB,Amgen/Novartis,CHEMBL3833329,CGRP receptor antibody,Migraine,migraine disorder,MONDO_0005277,Neurological,S,2018,ENSG00000064989,TRUE
Lokelma,Sodium zirconium cyclosilicate,SODIUM ZIRCONIUM CYCLOSILICATE,AstraZeneca,CHEMBL3301592,Potassium binder,Hyperkalaemia,hyperkalemia,HP_0002153,Nephrology,S,2018,NA,NA
Doptelet,Avatrombopag,AVATROMBOPAG,Dova Pharmaceuticals,CHEMBL2103883,Thrombopoietin receptor agonist,Thrombocytopenia,thrombocytopenia,HP_0001873,Hematology,P,2018,ENSG00000117400,TRUE
Palynziq,Pegvaliase,PEGVALIASE,BioMarin Pharmaceutical,CHEMBL4297802,PAL replacement therapy,Phenylketonuria,phenylketonuria,MONDO_0009861,Metabolic,"P, O",2018,NA,NA
Olumiant,Baricitinib,BARICITINIB,Incyte/Eli Lilly,CHEMBL2105759,JAK inhibitor,Rheumatoid arthritis,rheumatoid arthritis,EFO_0000685,Immunology,S,2018,"ENSG00000096968, ENSG00000162434",TRUE
Moxidectin,Moxidectin,MOXIDECTIN,Medicines Development for Global Health,CHEMBL2104415,Antihelmintic GABA receptor and glutamate channel modulator,River blindness,ocular onchocerciasis,EFO_0007398,Infectious,"P, O",2018,NA,NA
Epidiolex,Cannabidiol,CANNABIDIOL,GW Pharmaceuticals,CHEMBL190461,Cannabinoid,Dravet syndrome and Lennox-Gastaut syndrome,Dravet syndrome; Lennox-Gastaut syndrome,Orphanet_33069; MONDO_0016532,Neurological,"P, O",2018,ENSG00000118432,TRUE
Zemdri,Plazomicin,PLAZOMICIN,Achaogen,CHEMBL1650559,Aminoglycoside antibacterial,Urinary tract infections,urinary tract infection,EFO_0003103,Infectious,P,2018,NA,NA
Mektovi,Binimetinib,BINIMETINIB,Array BioPharma,CHEMBL3187723,MEK inhibitor,BRAF-mutated melanoma,melanoma,EFO_0000756,Oncology,"S, O",2018,"ENSG00000169032, ENSG00000126934",TRUE
Braftovi,Encorafenib,ENCORAFENIB,Array BioPharma,CHEMBL3301612,BRAF inhibitor,BRAF-mutated melanoma,melanoma,EFO_0000756,Oncology,"S, O",2018,ENSG00000157764,TRUE
TPOXX,Tecovirimat,TECOVIRIMAT,SIGA Technologies,CHEMBL1257073,Viral p37 protein inhibitor,Smallpox,smallpox,MONDO_0004651,Infectious,"P, O",2018,NA,NA
Tibsovo,Ivosidenib,IVOSIDENIB,Agios Pharmaceuticals,CHEMBL3989958,IDH1 inhibitor,"IDH1-mutated AML, Locally Advanced or Metastatic Cholangiocarcinoma (*)",acute myeloid leukemia; cholangiocarcinoma,EFO_0000222; EFO_0005221,Oncology,"P, O",2018,ENSG00000138413,TRUE
Krintafel,Tafenoquine,TAFENOQUINE,Medicines for Malaria Venture/GlaxoSmithKline,CHEMBL298470,8-Aminoquinoline antimalarial,Plasmodium vivax malaria,Plasmodium vivax malaria,EFO_0007445,Infectious,"P, O, B",2018,NA,NA
Orilissa,Elagolix sodium,ELAGOLIX SODIUM,AbbVie,CHEMBL502182,GnRH receptor antagonist,Pain associated with endometriosis,adenomyosis; pain,MONDO_0010888; EFO_0003843,Other,P,2018,ENSG00000109163,TRUE
Omegaven,Fish oil triglycerides,FISH OIL TRIGLYCERIDES,Fresenius,CHEMBL4297535,Mixture of fatty acids,Parenteral nutrition-associated cholestasis,cholestasis,MONDO_0001751,Other,"P, O",2018,ENSG00000151067,TRUE
Mulpleta,Lusutrombopag,LUSUTROMBOPAG,Shionogi,CHEMBL2107831,Thrombopoietin receptor agonist,Thrombocytopenia,thrombocytopenia,HP_0001873,Hematology,P,2018,ENSG00000117400,TRUE
Poteligeo,Mogamulizumab,MOGAMULIZUMAB,Kyowa Hakko Kirin,CHEMBL1743041,CCR4 antibody,mycosis fungoides or Sezary syndrome,mycosis fungoides,EFO_1001051,Oncology,"P, O, B",2018,ENSG00000183813,TRUE
Onpattro,Patisiran,PATISIRAN,Alnylam Pharmaceuticals,CHEMBL3989987,TTR-directed small interfering RNA,Hereditary TTR-mediated amyloidosis,hereditary ATTR amyloidosis,MONDO_0017132,Metabolic,"P, O, B",2018,ENSG00000118271,TRUE
Annovera,Segesterone acetate; ethinyl estradiol,SEGESTERONE ACETATE,TherapeuticsMD,CHEMBL3707377,Progestin and estrogen combined hormonal contraceptive,Female contraception,contraception,EFO_0009520,Other,S,2018,ENSG00000082175,TRUE
Annovera,Segesterone acetate; ethinyl estradiol,ETHINYL ESTRADIOL,TherapeuticsMD,CHEMBL691,Progestin and estrogen combined hormonal contraceptive,Female contraception,contraception,EFO_0009520,Other,S,2018,ENSG00000091831,TRUE
Galafold,Migalastat,MIGALASTAT,Amicus Therapeutics,CHEMBL110458,beta-galactosidase regulator,Fabry disease,fabry disease,MONDO_0010526,Metabolic,"P, O, A",2018,ENSG00000102393,TRUE
Diacomit,Stiripentol,STIRIPENTOL,Biocodex,CHEMBL1983350,GABA reuptake inhibitor,Dravet syndrome,dravet syndrome,Orphanet_33069,Neurological,"P, O",2018,ENSG00000022355,TRUE
Oxervate,Cenegermin,CENEGERMIN,Domp‚àö¬©,CHEMBL4297852,Recombinant NGF,Neurotrophic keratitis,keratitis,EFO_0009449,Ophthalmology,"P, O, B",2018,"ENSG00000140538, ENSG00000148053, ENSG00000198400",TRUE
Takhzyro,Lanadelumab,LANADELUMAB,Dyax/Shire,CHEMBL3545189,Kallikrein antibody,Hereditary angioedema,hereditary angioedema,MONDO_0019623,Immunology,"P, O, B",2018,ENSG00000164344,FALSE
Xerava,Eravacycline,ERAVACYCLINE,Tetraphase Pharmaceuticals,CHEMBL1951095,Tetracycline antibiotic,Complicated intra-abdominal infections,infectious disease,EFO_0005741,Infectious,P,2018,NA,NA
Pifeltro,Doravirine,DORAVIRINE,Merck & Co.,CHEMBL2364608,NNRTI,HIV,hiv infection,EFO_0000764,Infectious,S,2018,NA,NA
Lumoxiti,Moxetumomab pasudotox,MOXETUMOMAB PASUDOTOX,AstraZeneca,CHEMBL1743043,CD22-directed antibody‚Äö√Ñ√¨drug conjugate,Hairy cell leukaemia,hairy cell leukemia,EFO_1000956,Oncology,"P, O",2018,"ENSG00000167658, ENSG00000012124",TRUE
Ajovy,Fremanezumab,FREMANEZUMAB,Teva,CHEMBL4297756,CGRP antibody,Migraine,migraine disorder,MONDO_0005277,Neurological,P,2018,"ENSG00000110680, ENSG00000175868",TRUE
Copiktra,Duvelisib,DUVELISIB,Verastem,CHEMBL3039502,PI3K inhibitor,"CLL, FL and SLL",chronic lymphocytic leukemia; follicular lymphoma,EFO_0000095; MONDO_0018906,Oncology,"P, O, A",2018,"ENSG00000105851, ENSG00000171608",TRUE
Emgality,Galcanezumab,GALCANEZUMAB,Eli Lilly,CHEMBL3707328,CGRP antibody,Migraine,migraine disorder,MONDO_0005277,Neurological,S,2018,"ENSG00000175868, ENSG00000110680",TRUE
Vizimpro,Dacomitinib,DACOMITINIB,Pfizer,CHEMBL2105719,EGFR inhibitor,EGFR-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O",2018,"ENSG00000178568, ENSG00000146648, ENSG00000141736",TRUE
Libtayo,Cemiplimab,CEMIPLIMAB,Regeneron/Sanofi,CHEMBL4297723,PD1 antibody,"CSCC, BCC(*), NSCLC(*)",cutaneous squamous cell carcinoma; basal cell carcinoma; non-small cell lung carcinoma,EFO_1001927; EFO_0004193; EFO_0003060,Oncology,"P, B",2018,ENSG00000188389,TRUE
Seysara,Sarecycline,SARECYCLINE,Allergan,CHEMBL2364632,Tetracycline antibiotic,Severe acne vulgaris,acne,EFO_0003894,"Dermatology, infectious",S,2018,NA,NA
Nuzyra,Omadacycline,OMADACYCLINE,Paratek Pharmaceuticals,CHEMBL1689772,Tetracycline antibiotic,CABP and ABSSSI,bacterial pneumonia; skin disease caused by bacterial infection,EFO_1001272; MONDO_0024295,"Dermatology, infectious",P,2018,NA,NA
Revcovi,Elapegademase,ELAPEGADEMASE,Leadiant Biosciences,CHEMBL3990026,Recombinant adenosine deaminase,ADA-SCID,"severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency",MONDO_0007064,Immunology,"P, O",2018,ENSG00000196839,TRUE
Tegsedi,Inotersen,INOTERSEN,Ionis Pharmaceuticals,CHEMBL4297770,TTR-directed antisense oligonucleotide,Hereditary TTR-mediated amyloidosis,hereditary ATTR amyloidosis,MONDO_0017132,Metabolic,"P, O",2018,ENSG00000118271,TRUE
Talzenna,Talazoparib,TALAZOPARIB,Pfizer,CHEMBL3137320,PARP inhibitor,BRCA-mutated HER2-negative breast cancer,HER2 negative breast carcinoma,EFO_0009780,Oncology,P,2018,"ENSG00000143799, ENSG00000129484",TRUE
Xofluza,Baloxavir marboxil,BALOXAVIR MARBOXIL,Shionogi/Roche,CHEMBL4297503,Polymerase acidic endonuclease inhibitor,Acute uncomplicated influenza,influenza,EFO_0007328,Infectious,P,2018,NA,NA
Lorbrena,Lorlatinib,LORLATINIB,Pfizer,CHEMBL3286830,ALK and ROS1 inhibitor,ALK-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2018,"ENSG00000171094, ENSG00000143924",TRUE
Yupelri,Revefenacin,REVEFENACIN,Theravance Biopharma/Mylan,CHEMBL3833319,Long-acting muscarinic receptor antagonist,COPD,chronic obstructive pulmonary disease,EFO_0000341,Respiratory,S,2018,ENSG00000133019,TRUE
Aemcolo,Rifamycin,RIFAMYCIN,Cosmo Technologies,CHEMBL437765,Ansamycin antibacterial,Travellers diarrhoea,Diarrhea,HP_0002014,Infectious,P,2018,NA,NA
Gamifant,Emapalumab,EMAPALUMAB,Novimmune,CHEMBL3989977,Interferon-≈í‚â•-blocking antibody,Primary haemophagocytic lymphohistiocytosis,genetic hemophagocytic lymphohistiocytosis,MONDO_0015541,Hematology,"P, O, B",2018,ENSG00000111537,TRUE
Daurismo,Glasdegib,GLASDEGIB,Pfizer,CHEMBL2043437,Hedgehog pathway inhibitor,AML,NA,EFO_0000222,Oncology,"P, O",2018,ENSG00000128602,TRUE
Vitrakvi,Larotrectinib,LAROTRECTINIB,Loxo Oncology/Bayer,CHEMBL3889654,"TRKA, TRKB and TRKC inhibitor",NTRK-positive solid cancers,salivary gland cancer; soft tissue sarcoma; thyroid cancer,MONDO_0004669; EFO_1001968; MONDO_0002108,Oncology,"P, O, B, A",2018,"ENSG00000148053, ENSG00000198400, ENSG00000140538",TRUE
Xospata,Gilteritinib,GILTERITINIB,Astellas,CHEMBL3301622,FLT3 inhibitor,FLT3-positive AML,acute myeloid leukemia,EFO_0000222,Oncology,"P, O, B",2018,"ENSG00000122025, ENSG00000167601",TRUE
Firdapse,Amifampridine,AMIFAMPRIDINE,Catalyst Pharmaceuticals,CHEMBL354077,Potassium channel blocker,Lambert-Eaton myasthenic syndrome,Lambert-Eaton myasthenic syndrome,Orphanet_43393,Neurological,"P, O",2018,"ENSG00000130037, ENSG00000182255, ENSG00000173826, ENSG00000111262, ENSG00000178342, ENSG00000131398, ENSG00000140015, ENSG00000055118, ENSG00000168418, ENSG00000143473, ENSG00000183960, ENSG00000151079, ENSG00000184408, ENSG00000116396, ENSG00000171126, ENSG00000168263, ENSG00000026559, ENSG00000170745, ENSG00000185760, ENSG00000135519, ENSG00000184156, ENSG00000075043, ENSG00000117013, ENSG00000158445, ENSG00000166006, ENSG00000129159, ENSG00000124134, ENSG00000156486, ENSG00000143105, ENSG00000182674, ENSG00000053918, ENSG00000089558, ENSG00000177301, ENSG00000162975, ENSG00000102057, ENSG00000184611, ENSG00000171385, ENSG00000177272, ENSG00000104848, ENSG00000164794",FALSE
Motegrity,Prucalopride,PRUCALOPRIDE,Shire/Takeda,CHEMBL117287,5-HT4-receptor agonist,Chronic idiopathic constipation,constipation disorder,MONDO_0002203,Gastrointestinal,S,2018,ENSG00000164270,FALSE
Asparlas,Calaspargase pegol,CALASPARGASE PEGOL,Servier,CHEMBL2108728,Asparagine specific enzyme,ALL,acute lymphoblastic leukemia,EFO_0000220,Oncology,"S, O",2018,ENSG00000166183,FALSE
Ultomiris,Ravulizumab,RAVULIZUMAB,Alexion,CHEMBL3989986,Complement inhibitor,"Paroxysmal nocturnal haemoglobinuria, atypical hemolytic uremic syndrome (*), generalized myasthenia gravis AChR+ (*)","paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, Myasthenia gravis",MONDO_0100244; MONDO_0016244; EFO_0004991,Hematology,"S, O",2018,ENSG00000106804,TRUE
Elzonris,Tagraxofusp,TAGRAXOFUSP,Stemline Therapeutics,CHEMBL4297573,IL-3 and diphtheria toxin fusion protein,Blastic plasmacytoid dendritic cell neoplasm,blastic plasmacytoid dendritic cell neoplasm,EFO_0010580,Oncology,"P, O, B",2018,"ENSG00000167658, ENSG00000185291",FALSE
Jeuveau,Prabotulinumtoxin A,PRABOTULINUMTOXIN A,Evolus,CHEMBL4297229,Acetylcholine release inhibitor and a neuromuscular blocking agent,Glabellar lines associated with corrugator and/or procerus muscle activity,Facial wrinkling,HP_0009762,Other,S,2019,ENSG00000132639,FALSE
Cablivi,Caplacizumab,CAPLACIZUMAB,Sanofi/Ablynx,CHEMBL2109624,vWF-directed nanobody,ATTP,thrombotic thrombocytopenic purpura,MONDO_0018896,Hematology,"P, O",2019,ENSG00000110799,TRUE
Egaten,Triclabendazole,TRICLABENDAZOLE,Novartis,CHEMBL1086440,Anthelmintic,Fascioliasis,fascioliasis,EFO_1001324,Infectious,"P, O",2019,NA,NA
Zulresso,Brexanolone,BREXANOLONE,Sage Therapeutics,CHEMBL207538,GABAA-receptor-positive modulator,Postpartum depression,postpartum depression,EFO_0007453,Mental health,"P, B",2019,"ENSG00000094755, ENSG00000109158, ENSG00000186297, ENSG00000022355, ENSG00000145864, ENSG00000166206, ENSG00000182256, ENSG00000011677, ENSG00000268089, ENSG00000102287, ENSG00000113327, ENSG00000163285, ENSG00000151834, ENSG00000145863, ENSG00000163288, ENSG00000187730",TRUE
Sunosi,Solriamfetol,SOLRIAMFETOL,Jazz,CHEMBL4297620,Dopamine and noradrenaline reuptake inhibitor,Excessive sleepiness due to narcolepsy or obstructive sleep apnoea,hypersomnia; narcolepsy; obstructive sleep apnea,EFO_0005246; MONDO_0021107; EFO_0003918,Other,"S, O",2019,"ENSG00000142319, ENSG00000103546",TRUE
Mayzent,Siponimod,SIPONIMOD,Novartis,CHEMBL2336071,S1P receptor modulator,Relapsing forms of multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,Neurological,S,2019,"ENSG00000170989, ENSG00000168610",TRUE
Evenity,Romosozumab,ROMOSOZUMAB,Amgen,CHEMBL2107874,Sclerostin inhibitor,Osteoporosis,osteoporosis,EFO_0003882,Endocrine,S,2019,ENSG00000167941,TRUE
Balversa,Erdafitinib,ERDAFITINIB,Janssen /J&J,CHEMBL3545376,FGFR inhibitor,Bladder cancer,urinary bladder carcinoma,MONDO_0004986,Oncology,"P, B, A",2019,"ENSG00000077782, ENSG00000066468, ENSG00000160867, ENSG00000068078",TRUE
Skyrizi,Risankizumab,RISANKIZUMAB,AbbVie,CHEMBL3990029,IL-23 antagonist,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,Dermatology,S,2019,"ENSG00000110944, ENSG00000113302",TRUE
Vyndaqel,Tafamidis,TAFAMIDIS,Pfizer/Foldrx,CHEMBL2103837,Transthyretin stabilizer,Heart disease caused by ATTR-CM,cardiomyopathy,EFO_0000318,Cardiovascular,"P, O, B",2019,ENSG00000118271,TRUE
Piqray,Alpelisib,ALPELISIB,Novartis,CHEMBL2396661,PI3K inhibitor,Breast cancer,breast cancer,MONDO_0007254,Oncology,P,2019,ENSG00000121879,TRUE
Polivy,Polatuzumab vedotin,POLATUZUMAB VEDOTIN,Roche,CHEMBL3301582,CD79b-directed ADC,Diffuse large B-cell lymphoma,diffuse large b-cell lymphoma,EFO_0000403,Oncology,"P, O, B, A",2019,"ENSG00000198033, ENSG00000167552, ENSG00000261456, ENSG00000176014, ENSG00000258947, ENSG00000123416, ENSG00000101162, ENSG00000188229, ENSG00000152086, ENSG00000007312, ENSG00000137285, ENSG00000167553, ENSG00000196230, ENSG00000137267, ENSG00000127824, ENSG00000104833",TRUE
Vyleesi,Bremelanotide,BREMELANOTIDE,Amag,CHEMBL2070241,Melanocortin receptor agonist,Hypoactive sexual desire disorder,sexual dysfunction,EFO_0004714,Other,S,2019,ENSG00000166603,TRUE
Xpovio,Selinexor,SELINEXOR,Karyopharm Therapeutics,CHEMBL3545185,XPO1 inhibitor,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O, A",2019,ENSG00000082898,TRUE
Recarbrio,Cilastatin; imipenem; relebactam,CILASTATIN,Merck & Co.,CHEMBL766,"A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor",Complicated urinary tract and complicated intra-abdominal infections,urinary tract infection,EFO_0003103,Infectious,P,2019,ENSG00000015413,NA
Recarbrio,Cilastatin; imipenem; relebactam,IMIPENEM,Merck & Co.,CHEMBL148,"A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor",Complicated urinary tract and complicated intra-abdominal infections,urinary tract infection,EFO_0003103,Infectious,P,2019,NA,NA
Recarbrio,Cilastatin; imipenem; relebactam,RELEBACTAM,Merck & Co.,CHEMBL3301605,"A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor",Complicated urinary tract and complicated intra-abdominal infections,urinary tract infection,EFO_0003103,Infectious,P,2019,NA,NA
Accrufer,Ferric maltol,FERRIC MALTOL,Shield Therapeutics,CHEMBL4298110,Iron replacement product,Iron deficiency anaemia,iron deficiency anemia,HP_0001891,Hematology,S,2019,"ENSG00000259207, ENSG00000110911",TRUE
Nubeqa,Darolutamide,DAROLUTAMIDE,Bayer,CHEMBL4297185,Androgen receptor inhibitor,Prostate cancer,prostate cancer,MONDO_0008315,Oncology,P,2019,ENSG00000169083,TRUE
Turalio,Pexidartinib,PEXIDARTINIB,Daiichi Sankyo,CHEMBL3813873,"CSF1R, KIT and FLT3 inhibitor",Tenosynovial giant cell tumour,Tenosynovial Giant Cell Tumor,EFO_1000562,Oncology,"P, O, B",2019,"ENSG00000182578, ENSG00000122025, ENSG00000157404",TRUE
Wakix,Pitolisant,PITOLISANT,Harmony,CHEMBL462605,H3-receptor antagonist/inverse agonist,Excessive sleepiness due to narcolepsy,narcolepsy,MONDO_0021107,Neurological,"P, O",2019,ENSG00000101180,FALSE
Pretomanid,Pretomanid,PRETOMANID,Pfizer/Mylan,CHEMBL227875,Antimycobacterial,Tuberculosis,tuberculosis,MONDO_0018076,Infectious,"P, O",2019,NA,NA
Rozlytrek,Entrectinib,ENTRECTINIB,Roche,CHEMBL1983268,"TRKA, TRKB, TRKC, ROS1 and ALK inhibitor",NTRK fusion-positive solid tumours and ROS1-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2019,"ENSG00000148053, ENSG00000198400, ENSG00000140538, ENSG00000047936, ENSG00000171094",TRUE
Rinvoq,Upadacitinib,UPADACITINIB,AbbVie,CHEMBL3622821,JAK inhibitor,Rheumatoid arthritis,rheumatoid arthritis,EFO_0000685,Immunology,S,2019,"ENSG00000162434, ENSG00000096968, ENSG00000105397, ENSG00000105639",TRUE
Inrebic,Fedratinib,FEDRATINIB,Celgene/BMS,CHEMBL1287853,JAK2 and FLT3 inhibitor,Myelofibrosis,myelofibrosis,MONDO_0044903,Hematology,"P, O",2019,"ENSG00000096968, ENSG00000122025",TRUE
Xenleta,Lefamulin,LEFAMULIN,Nabriva,CHEMBL3291398,Pleuromutilin antibacterial,CABP,bacterial pneumonia,EFO_1001272,"Respiratory, infectious",P,2019,NA,NA
Gallium dotatoc Ga-68,Gallium dotatoc Ga-68,GALLIUM DOTATOC GA-68,UIHC PET Imaging Center,CHEMBL4297340,Radioactive diagnostic,Localization of somatostatin receptor-positive neuroendocrine tumours,neuroendocrine neoplasm,EFO_1001901,Imaging,"S, O",2019,ENSG00000180616,TRUE
Nourianz,Istradefylline,ISTRADEFYLLINE,Kyowa Kirin,CHEMBL431770,Adenosine receptor antagonist,Parkinson disease episodes,Parkinson disease,MONDO_0005180,Neurological,S,2019,ENSG00000128271,TRUE
Ibsrela,Tenapanor,TENAPANOR,Ardelyx,CHEMBL3304485,NHE3 inhibitor,IBS with constipation,irritable bowel syndrome,EFO_0000555,Gastrointestinal,S,2019,ENSG00000066230,FALSE
Aklief,Trifarotene,TRIFAROTENE,Galderma,CHEMBL3707313,Retinoic acid receptor agonist,Acne vulgaris,acne,EFO_0003894,Dermatology,S,2019,ENSG00000172819,FALSE
Beovu,Brolucizumab,BROLUCIZUMAB,Novartis,CHEMBL3707357,VEGF inhibitor,Wet age-related macular degeneration,macular degeneration,EFO_0009606,Ophthalmology,S,2019,ENSG00000112715,TRUE
Scenesse,Afamelanotide,AFAMELANOTIDE,Clinuvel,CHEMBL441738,Melanocortin 1 receptor agonist,Erythropoietic protoporphyria,erythropoietic protoporphyria,MONDO_0001676,Dermatology,"P, O",2019,ENSG00000258839,TRUE
Fluorodopa F-18,Fluorodopa F-18,FLUORODOPA F-18,Feinstein Institutes,CHEMBL3400972,Radioactive diagnostic,Diagnosis of parkinsonian syndromes,Parkinson disease,MONDO_0005180,Imaging,S,2019,NA,NA
Reyvow,Lasmiditan,LASMIDITAN,Eli Lilly,CHEMBL3039520,Serotonin (5-HT) 1F receptor agonist,Migraine with or without aura,migraine disorder,MONDO_0005277,Neurological,S,2019,ENSG00000179097,FALSE
Trikafta,Tezacaftor; elexacaftor; ivacaftor,TEZACAFTOR,Vertex,CHEMBL3544914,Two CFTR correctors and a CFTR potentiator,Most common gene mutation that causes cystic fibrosis,cystic fibrosis,MONDO_0009061,Metabolic,"P, O, B",2019,ENSG00000001626,TRUE
Trikafta,Tezacaftor; elexacaftor; ivacaftor,ELEXACAFTOR,Vertex,CHEMBL4298128,Two CFTR correctors and a CFTR potentiator,Most common gene mutation that causes cystic fibrosis,cystic fibrosis,MONDO_0009061,Metabolic,"P, O, B",2019,ENSG00000001626,TRUE
Trikafta,Tezacaftor; elexacaftor; ivacaftor,IVACAFTOR,Vertex,CHEMBL2010601,Two CFTR correctors and a CFTR potentiator,Most common gene mutation that causes cystic fibrosis,cystic fibrosis,MONDO_0009061,Metabolic,"P, O, B",2019,ENSG00000001626,TRUE
ExEm Foam,Air polymer-type A,AIR POLYMER-TYPE A,Giskit,CHEMBL4594264,Ultrasound contrast agent,Assess fallopian tube patency in women with known or suspected infertility,infertility,EFO_0000545,Imaging,S,2019,NA,NA
Reblozyl,Luspatercept,LUSPATERCEPT,Celgene/BMS,CHEMBL3039545,Erythroid maturation agent,Anaemia in beta-thalassaemia,beta thalassemia; anemia,MONDO_0019402; MONDO_0002280,Hematology,"P, O",2019,"ENSG00000105329, ENSG00000092969, ENSG00000119699",TRUE
Fetroja,Cefiderocol,CEFIDEROCOL,Shionogi,CHEMBL3989974,Cephalosporin antibacterial,Complicated urinary tract infections,urinary tract infection,EFO_0003103,Infectious,P,2019,NA,NA
Brukinsa,Zanubrutinib,ZANUBRUTINIB,BeiGene,CHEMBL3936761,BTK inhibitor,Mantle cell lymphoma,mantle cell lymphoma,EFO_1001469,Oncology,"P, O, B, A",2019,ENSG00000010671,TRUE
Adakveo,Crizanlizumab,CRIZANLIZUMAB,Novartis,CHEMBL4297734,P-selectin blocker,Painful complications of SCD,sickle cell disease and related diseases,MONDO_0017146,Hematology,"P, O, B",2019,ENSG00000174175,FALSE
Givlaari,Givosiran,GIVOSIRAN,Alnylam,CHEMBL4297760,ALAS1-directed siRNA,Acute hepatic porphyria,acute hepatic porphyria,Orphanet_95157,Metabolic,"P, O, B",2019,ENSG00000023330,FALSE
Xcopri,Cenobamate,CENOBAMATE,SK Life Science,CHEMBL3989949,Unknown,Partial onset seizures,seizure,HP_0001250,Neurological,S,2019,"ENSG00000168356, ENSG00000196876, ENSG00000185313, ENSG00000144285, ENSG00000153253, ENSG00000183873, ENSG00000136531, ENSG00000169432, ENSG00000136546, ENSG00000007314, ENSG00000186297, ENSG00000151834, ENSG00000011677, ENSG00000187730, ENSG00000109158, ENSG00000022355, ENSG00000166206, ENSG00000182256, ENSG00000145864, ENSG00000268089, ENSG00000145863, ENSG00000094755, ENSG00000163288, ENSG00000113327, ENSG00000102287, ENSG00000163285",TRUE
Oxbryta,Voxelotor,VOXELOTOR,Global Blood Therapeutics,CHEMBL4101807,Haemoglobin S polymerization inhibitor,SCD (sickle cell disease),sickle cell anemia,MONDO_0011382,Hematology,"P, O, B, A",2019,"ENSG00000206172, ENSG00000244734, ENSG00000188536",TRUE
Vyondys 53,Golodirsen,GOLODIRSEN,Sarepta,CHEMBL4297762,Exon 53 skipping antisense,Duchenne muscular dystrophy,duchenne muscular dystrophy,MONDO_0010679,Neurological,"P, O, A",2019,ENSG00000198947,TRUE
Padcev,Enfortumab vedotin,ENFORTUMAB VEDOTIN,Astellas,CHEMBL3301589,Nectin-4-directed ADC,Urothelial cancers,urothelial neoplasm,MONDO_0024337,Oncology,"P, B, A",2019,"ENSG00000143217, ENSG00000101162, ENSG00000167552, ENSG00000261456, ENSG00000127824, ENSG00000123416, ENSG00000258947, ENSG00000198033, ENSG00000188229, ENSG00000152086, ENSG00000137267, ENSG00000104833, ENSG00000167553, ENSG00000137285, ENSG00000196230, ENSG00000176014",TRUE
Tissueblue,Brilliant Blue G,BRILLIANT BLUE G,Dutch Ophthalmic Research,CHEMBL4173394,Brilliant Blue G dye,Staining the internal limiting membrane,NA,NA,Other,"P, O",2019,NA,NA
Dayvigo,Lemborexant,LEMBOREXANT,Eisai,CHEMBL3545367,Orexin receptor antagonist,Insomnia,insomnia,EFO_0004698,Neurological,S,2019,"ENSG00000121764, ENSG00000137252",TRUE
Enhertu,Trastuzumab deruxtecan,TRASTUZUMAB DERUXTECAN,Daiichi Sankyo/AstraZeneca,CHEMBL4297844,HER2-directed ADC,HER2-positive breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,Oncology,"P, B, A",2019,"ENSG00000141736, ENSG00000198900",TRUE
Caplyta,Lumateperone,LUMATEPERONE,Intra-Cellular Therapies,CHEMBL3306803,Atypical antipsychotic,Schizophrenia,schizophrenia,MONDO_0005090,Neurological,S,2019,"ENSG00000102468, ENSG00000108576, ENSG00000149295",TRUE
Ubrelvy,Ubrogepant,UBROGEPANT,Allergan,CHEMBL2364638,CGRP receptor antagonist,Migraine with or without aura,migraine disorder,MONDO_0005277,Neurological,S,2019,ENSG00000064989,TRUE
Ayvakit,Avapritinib,AVAPRITINIB,Blueprint Medicines,CHEMBL4204794,"PDGFRA, PDGFRA mutants and KIT kinase inhibitor",GIST with PDGFRA exon 18 mutations,gastrointestinal stromal tumor,MONDO_0011719,Oncology,"P, O, B",2020,"ENSG00000157404, ENSG00000134853",TRUE
Tepezza,Teprotumumab,TEPROTUMUMAB,Horizon Therapeutics,CHEMBL1743079,IGF1R-directed mAb,Thyroid eye disease,Graves disease,EFO_0004237,Ophthalmology,"P, O, B",2020,ENSG00000140443,FALSE
Tazverik,Tazemetostat,TAZEMETOSTAT,Epizyme,CHEMBL3414621,EZH2 inhibitor,Epithelioid sarcoma,epithelioid sarcoma,MONDO_0017387,Oncology,"P, O, A",2020,ENSG00000106462,TRUE
Pizensy,Lactitol,LACTITOL,Braintree Labs,CHEMBL1661,Osmotic laxative,Chronic idiopathic constipation,Chronic constipation,HP_0012450,Other,S,2020,NA,NA
Vyepti,Eptinezumab,EPTINEZUMAB,Lundbeck,CHEMBL3833320,CGRP-directed mAb,Migraine,migraine disorder,MONDO_0005277,Other,S,2020,"ENSG00000110680, ENSG00000175868",TRUE
Nexletol,Bempedoic acid,BEMPEDOIC ACID,Esperion Therapeutics,CHEMBL3545313,ACL inhibitor,HeFH or atherosclerotic cardiovascular disease,atherosclerosis; familial hypercholesterolemia,EFO_0003914; EFO_0004911,Cardiovascular,S,2020,ENSG00000131473,FALSE
Barhemsys,Amisulpride,AMISULPRIDE,Acacia,CHEMBL243712,Dopamine receptors D2 & D3 antagonist,Nausea and vomiting after surgery,Nausea and vomiting,HP_0002017,Other,S,2020,"ENSG00000151577, ENSG00000149295, ENSG00000164270, ENSG00000157219, ENSG00000158748, ENSG00000166736, ENSG00000186090, ENSG00000178084, ENSG00000102468, ENSG00000149305, ENSG00000179097, ENSG00000135914, ENSG00000178394, ENSG00000168830, ENSG00000147246, ENSG00000186038, ENSG00000148680, ENSG00000135312, ENSG00000179546",FALSE
Nurtec ODT,Rimegepant,RIMEGEPANT,Biohaven,CHEMBL2178422,CGRP receptor antagonist,Migraine,migraine disorder,MONDO_0005277,Other,S,2020,ENSG00000064989,TRUE
Sarclisa,Isatuximab,ISATUXIMAB,Sanofi,CHEMBL3545131,CD38-directed mAb,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"S, O",2020,ENSG00000004468,TRUE
Isturisa,Osilodrostat,OSILODROSTAT,Recordati Rare Diseases,CHEMBL3099695,Cortisol synthesis inhibitor,Cushing disease,Cushing syndrome,EFO_0003099,Endocrine,"S, O",2020,ENSG00000160882,TRUE
Zeposia,Ozanimod,OZANIMOD,Celgene/Bristol Myers Squibb,CHEMBL3707247,S1P receptor modulator,Multiple sclerosis,multiple sclerosis,MONDO_0005301,Other,S,2020,ENSG00000170989,TRUE
Koselugo,Selumetinib,SELUMETINIB,AstraZeneca,CHEMBL1614701,MEK1/2 kinase inhibitor,Neurofibromatosis type 1,neurofibromatosis type 1,MONDO_0018975,Other,"P, O, B",2020,"ENSG00000169032, ENSG00000126934",TRUE
Tukysa,Tucatinib,TUCATINIB,Seagen,CHEMBL3989868,HER2 kinase inhibitor,HER2-positive breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,Oncology,"P, O, B",2020,ENSG00000141736,TRUE
Pemazyre,Pemigatinib,PEMIGATINIB,Incyte,CHEMBL4297522,FGFR1-3 kinase inhibitor,Cholangiocarcinoma,cholangiocarcinoma,EFO_0005221,Oncology,"P, O, B, A",2020,"ENSG00000066468, ENSG00000068078, ENSG00000077782",TRUE
Trodelvy,Sacituzumab govitecan,SACITUZUMAB GOVITECAN,Immunomedics/Gilead,CHEMBL3545262,"TROP2-directed ADC, with topoisomerase inhibitor",Triple-negative breast cancer (and advanced or metastatic urothelial cancer (mUC)*),triple-negative breast cancer; urothelial carcinoma,EFO_0005537; EFO_0008528,Oncology,"P, B, A",2020,"ENSG00000198900, ENSG00000184292",TRUE
Ongentys,Opicapone,OPICAPONE,Neurocrine,CHEMBL1089318,COMT inhibitor,Parkinson disease,parkinson disease,MONDO_0005180,Neurological,S,2020,ENSG00000093010,TRUE
Tabrecta,Capmatinib,CAPMATINIB,Novartis,CHEMBL3188267,MET kinase inhibitor,NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2020,ENSG00000105976,TRUE
Retevmo,Selpercatinib,SELPERCATINIB,Eli Lilly/Loxo Oncology,CHEMBL4559134,RET kinase inhibitor,RET fusion-positive NSCLC and thyroid cancer,non-small cell lung carcinoma; thyroid cancer,EFO_0003060; MONDO_0002108,Oncology,"P, O, B, A",2020,"ENSG00000108091, ENSG00000165731, ENSG00000170759",TRUE
Qinlock,Ripretinib,RIPRETINIB,Deciphera,CHEMBL4216467,KIT and PDGFRA kinase inhibitor,GIST,gastrointestinal stromal tumor,MONDO_0011719,Oncology,"P, O, B",2020,"ENSG00000157404, ENSG00000134853",TRUE
Fluoroestradiol F-18,Fluoroestradiol F-18,FLUOROESTRADIOL F-18,Zionexa,CHEMBL4594261,Radioactive diagnostic,"Imaging, breast cancer",breast carcinoma,EFO_0000305,Imaging,S,2020,"ENSG00000091831, ENSG00000140009, ENSG00000186868",TRUE
Artesunate,Artesunate,ARTESUNATE,Amivas,CHEMBL361497,Artemisinin antimalarial,Severe malaria,malaria,EFO_0001068,Infectious,"P, O, B",2020,NA,NA
Flortaucipir F-18,Flortaucipir F-18,FLORTAUCIPIR F-18,Eli Lilly,CHEMBL3545253,Radioactive diagnostic,"Imaging, tau in Alzheimer disease",Alzheimer disease,MONDO_0004975,Imaging,P,2020,ENSG00000186868,TRUE
Uplizna,Inebilizumab,INEBILIZUMAB,Viela Bio,CHEMBL2109334,CD19-directed mAb,NMOSD,neuromyelitis optica,EFO_0004256,Neurological,"S, O, B",2020,ENSG00000177455,FALSE
Zepzelca,Lurbinectedin,LURBINECTEDIN,Jazz,CHEMBL4297516,Alkylating drug,Small-cell lung cancer,small cell lung carcinoma,EFO_0000702,Oncology,"P, O, A",2020,NA,NA
Dojolvi,Triheptanoin,TRIHEPTANOIN,Ultragenyx,CHEMBL4297585,Medium-chain triglyceride,LC-FAODs,inherited fatty acid metabolism disorder,MONDO_0037858,Metabolic,"S, O",2020,NA,NA
Rukobia,Fostemsavir,FOSTEMSAVIR,ViiV Healthcare,CHEMBL3301594,Attachment inhibitor,HIV,hiv infection,EFO_0000764,Infectious,"P, B",2020,NA,NA
Byfavo,Remimazolam,REMIMAZOLAM,Acacia,CHEMBL4297526,Benzodiazepine,Procedural sedation,sedation,EFO_0009868,Other,S,2020,"ENSG00000102287, ENSG00000163288, ENSG00000186297, ENSG00000145864, ENSG00000113327, ENSG00000011677, ENSG00000094755, ENSG00000163285, ENSG00000151834, ENSG00000109158, ENSG00000268089, ENSG00000187730, ENSG00000182256, ENSG00000022355, ENSG00000145863, ENSG00000166206",TRUE
Inqovi,Cedazuridine; decitabine,CEDAZURIDINE,Otsuka,CHEMBL3237547,Cytidine deaminase inhibitor; nucleoside metabolic inhibitor,Myelodysplastic syndromes,myelodysplastic syndrome,EFO_0000198,Hematology,"P, O",2020,ENSG00000158825,TRUE
Inqovi,Cedazuridine; decitabine,DECITABINE,Otsuka,CHEMBL1201129,Cytidine deaminase inhibitor; nucleoside metabolic inhibitor,Myelodysplastic syndromes,myelodysplastic syndrome,EFO_0000198,Hematology,"P, O",2020,"ENSG00000119772, ENSG00000130816",TRUE
Xeglyze,Abametapir,ABAMETAPIR,Dr Reddy‚Äö√Ñ√∂‚àö√ë‚àö¬•s,CHEMBL2205807,Metalloproteinase inhibitor,Head lice,lice infestation,MONDO_0003472,"Dermatology, infectious",S,2020,NA,NA
Monjuvi,Tafasitamab,TAFASITAMAB,MorphoSys,CHEMBL4298047,CD19-directed mAb,DLBCL,diffuse large b-cell lymphoma,EFO_0000403,Oncology,"P, O, B, A",2020,ENSG00000177455,TRUE
Blenrep,Belantamab mafodotin,BELANTAMAB MAFODOTIN,GlaxoSmithKline,CHEMBL4298209,"BCMA-directed ADC, with microtubule inhibitor",Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O, B, A",2020,"ENSG00000048462, ENSG00000152086, ENSG00000167553, ENSG00000188229, ENSG00000137267, ENSG00000176014, ENSG00000261456, ENSG00000127824, ENSG00000123416, ENSG00000137285, ENSG00000258947, ENSG00000167552, ENSG00000198033, ENSG00000196230, ENSG00000104833, ENSG00000101162",TRUE
Lampit,Nifurtimox,NIFURTIMOX,Bayer,CHEMBL290960,Nitrofuran antiprotozoal,Chagas disease,chagas disease,MONDO_0001444,Infectious,"P, O, A",2020,NA,NA
Olinvyk,Oliceridine,OLICERIDINE,Trevena,CHEMBL2443262,Opioid receptor agonist,Acute pain,pain,EFO_0003843,Other,S,2020,ENSG00000112038,FALSE
Evrysdi,Risdiplam,RISDIPLAM,Roche/Genentech,CHEMBL4297528,SMN2 splicing modifier,Spinal muscular atrophy,spinal muscular atrophy,EFO_0008525,Neurological,"P, O",2020,ENSG00000205571,TRUE
Viltepso,Viltolarsen,VILTOLARSEN,Nippon Shinyaku,CHEMBL4298062,Dystrophin splicing modifier,Duchenne muscular dystrophy,duchenne muscular dystrophy,MONDO_0010679,Neurological,"P, O, A",2020,ENSG00000198947,TRUE
Enspryng,Satralizumab,SATRALIZUMAB,Roche/Genentech,CHEMBL3833307,IL-6R-directed mAb,NMOSD,neuromyelitis optica,EFO_0004256,Neurology,"S, O, B",2020,"ENSG00000160712, ENSG00000134352",TRUE
Winlevi,Clascoterone,CLASCOTERONE,Cassiopea SpA,CHEMBL3590187,Androgen receptor inhibitor,Acne vulgaris,acne,EFO_0003894,Dermatology,S,2020,ENSG00000169083,TRUE
Sogroya,Somapacitan,SOMAPACITAN,Novo Nordisk,CHEMBL3707290,Growth hormone analogue,Growth hormone deficiency,short stature due to partial GHR deficiency,MONDO_0011420,Endocrine,S,2020,ENSG00000112964,TRUE
Copper dotatate Cu-64,Copper dotatate Cu-64,COPPER DOTATATE CU-64,Radiomedix,CHEMBL4297339,Radioactive diagnostic,"Imaging, cancer",neuroendocrine neoplasm,EFO_1001901,Imaging,"P, O",2020,ENSG00000180616,TRUE
Gavreto,Pralsetinib,PRALSETINIB,Blueprint Medicines/Roche,CHEMBL4582651,RET kinase inhibitor,RET fusion-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2020,"ENSG00000170759, ENSG00000165731, ENSG00000108091",TRUE
Inmazeb,Atoltivimab; odesivimab; maftivimab,ATOLTIVIMAB,Regeneron,CHEMBL4298183,Cocktail of Ebola glycoprotein-directed mAbs,Ebola virus,Ebola hemorrhagic fever,EFO_0007243,Infectious,"P, O, B",2020,NA,NA
Inmazeb,Atoltivimab; odesivimab; maftivimab,ODESIVIMAB,Regeneron,CHEMBL4298188,Cocktail of Ebola glycoprotein-directed mAbs,Ebola virus,Ebola hemorrhagic fever,EFO_0007243,Infectious,"P, O, B",2020,NA,NA
Inmazeb,Atoltivimab; odesivimab; maftivimab,MAFTIVIMAB,Regeneron,CHEMBL4298184,Cocktail of Ebola glycoprotein-directed mAbs,Ebola virus,Ebola hemorrhagic fever,EFO_0007243,Infectious,"P, O, B",2020,NA,NA
Veklury,Remdesivir,REMDESIVIR,Gilead,CHEMBL4065616,Nucleotide analogue RNA polymerase inhibitor,COVID-19,covid-19,MONDO_0100096,Infectious,P,2020,NA,NA
Zokinvy,Lonafarnib,LONAFARNIB,Eiger,CHEMBL298734,Farnesyltransferase inhibitor,HGPS,hutchinson-gilford progeria syndrome,MONDO_0008310,Other,"P, O, B",2020,"ENSG00000257365, ENSG00000168522",FALSE
Oxlumo,Lumasiran,LUMASIRAN,Alnylam,CHEMBL4297779,HAO1-directed siRNA,Hyperoxaluria type 1,primary hyperoxaluria type 1,MONDO_0009823,Nephrology,"P, O, B",2020,ENSG00000101323,FALSE
Danyelza,Naxitamab,NAXITAMAB,Y-mAbs Therapeutics,CHEMBL4297984,GD2-directed mAb,High-risk neuroblastoma,neuroblastoma,EFO_0000621,Oncology,"P, O, B, A",2020,NA,NA
Imcivree,Setmelanotide,SETMELANOTIDE,Rhythm,CHEMBL3301624,Melanocortin receptor 4 agonist,Rare genetic diseases of obesity,Bardet-Biedl syndrome,MONDO_0015229,Other,"P, O, B",2020,ENSG00000166603,TRUE
PSMA-11 Ga-68,PSMA-11 Ga-68,PSMA-11 GA-68,UCLA,CHEMBL4297335,Radioactive diagnostic,"Imaging, prostate cancer",prostate carcinoma,EFO_0001663,Imaging,S,2020,ENSG00000142515,TRUE
Orladeyo,Berotralstat,BEROTRALSTAT,BioCryst,CHEMBL4594271,Plasma kallikrein inhibitor,Hereditary angioedema,NA,MONDO_0019623,Immunology,"S, O",2020,ENSG00000164344,FALSE
Klisyri,Tirbanibulin,TIRBANIBULIN,Athenex,CHEMBL571546,Microtubule inhibitor,Actinic keratosis,actinic keratosis,EFO_0002496,Dermatology,S,2020,ENSG00000197122,TRUE
Margenza,Margetuximab,MARGETUXIMAB,MacroGenics,CHEMBL2364649,HER2-directed mAb,HER2-positive breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,Oncology,S,2020,ENSG00000141736,TRUE
Orgovyx,Relugolix,RELUGOLIX,Myovant Sciences,CHEMBL1800159,GnRH receptor antagonist,Prostate cancer,prostate cancer,MONDO_0008315,Oncology,P,2020,ENSG00000109163,TRUE
Ebanga,Ansuvimab,ANSUVIMAB,Ridgeback,CHEMBL4594388,Ebola glycoprotein-directed mAb,Ebola virus,Ebola hemorrhagic fever,EFO_0007243,Infectious,"P, O, B",2020,NA,NA
Gemtesa,Vibegron,VIBEGRON,Urovant Sciences,CHEMBL2107826,Beta-3 adrenergic receptor agonist,Overactive bladder,overactive bladder,EFO_1000781,Other,S,2020,ENSG00000188778,FALSE
Verquvo,Vericiguat,Vericiguat,Merck & Co./Bayer,CHEMBL4066936,sGC stimulator,Chronic heart failure,coronary artery disease,EFO_0001645,Cardiovascular,P,2021,"ENSG00000123201, ENSG00000061918, ENSG00000152402, ENSG00000164116",TRUE
Cabenuva Kit,Cabotegravir; rilpivirine,Cabotegravir,ViiV,CHEMBL2403238,INSTI and an NNRTI,HIV-1 infection,NA,NA,Infectious,P,2021,NA,NA
Cabenuva Kit,Cabotegravir; rilpivirine,rilpivirine,ViiV,CHEMBL175691,INSTI and an NNRTI,HIV-1 infection,NA,NA,Infectious,P,2021,NA,NA
Lupkynis,Voclosporin,Voclosporin,Aurinia,CHEMBL2218919,Calcineurin inhibitor,Lupus nephritis,lupus nephritis,EFO_0005761,Nephrology,P,2021,ENSG00000138814,TRUE
Tepmetko,Tepotinib,Tepotinib,EMD Serono,CHEMBL3402762,MET kinase inhibitor,NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, A",2021,ENSG00000105976,TRUE
Ukoniq,Umbralisib,Umbralisib,TG Therapeutics,CHEMBL3948730,PI3Kdelta and CK1epsilon inhibitor,"MZL, follicular lymphoma",MZL; follicular lymphoma,EFO_1000630; MONDO_0018906,Oncology,"P, O, B, A",2021,"ENSG00000171608, ENSG00000097007, ENSG00000213923",TRUE
Evkeeza,Evinacumab,Evinacumab,Regeneron,CHEMBL3545191,ANGPTL3-targeted mAb,HoFH,homozygous familial hypercholesterolemia,MONDO_0018328,Metabolic,"P, O, B",2021,ENSG00000132855,TRUE
Cosela,Trilaciclib,Trilaciclib,G1 Therapeutics,CHEMBL3894860,CDK4 and CDK6 kinase inhibitor,Chemotherapy-induced myelosuppression,myelosuppression; small cell lung carcinoma,EFO_0007053; EFO_0000702,Oncology,"P, B",2021,"ENSG00000135446, ENSG00000105810",TRUE
Amondys 45,Casimersen,Casimersen,Sarepta,CHEMBL4297566,Exon 45-skipping ASO,DMD,Duchenne muscular dystrophy,MONDO_0010679,Other,"P, O, A",2021,ENSG00000198947,TRUE
Nulibry,Fosdenopterin,Fosdenopterin,BridgeBio,CHEMBL2338675,cPMP,MoCD type A,sulfite oxidase deficiency due to molybdenum cofactor deficiency,MONDO_0020480,Other,"P, O, B",2021,ENSG00000164172,TRUE
Pepaxto,Melphalan flufenamide,Melphalan flufenamide,Oncopeptides,CHEMBL4303060,Peptide-conjugated alkylating drug,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O, A",2021,NA,NA
Azstarys,Dexmethylphenidate; serdexmethylphenidate,Dexmethylphenidate,Commave Therapeutics,CHEMBL827,CNS stimulant,ADHD,attention deficit hyperactivity disorder,EFO_0003888,Psychiatric,S,2021,"ENSG00000103546, ENSG00000142319",TRUE
Azstarys,Dexmethylphenidate; serdexmethylphenidate,serdexmethylphenidate,Commave Therapeutics,CHEMBL4301162,CNS stimulant,ADHD,attention deficit hyperactivity disorder,EFO_0003888,Psychiatric,S,2021,"ENSG00000142319, ENSG00000103546",TRUE
Fotivda,Tivozanib,Tivozanib,Aveo,CHEMBL1289494,VEGFR kinase inhibitor,Renal cell carcinoma,renal cell carcinoma,EFO_0000681,Oncology,S,2021,"ENSG00000102755, ENSG00000128052, ENSG00000037280, ENSG00000157404, ENSG00000113721",TRUE
Ponvory,Ponesimod,Ponesimod,J&J,CHEMBL1096146,S1P receptor modulator,Relapsing multiple sclerosis,multiple sclerosis,MONDO_0005301,Other,S,2021,ENSG00000170989,TRUE
Zegalogue,Dasiglucagon,Dasiglucagon,Zealand Pharma,CHEMBL4297741,Glucagon receptor agonist,Severe hypoglycaemia,GCGR-related hyperglucagonemia,EFO_0001360,Metabolic,S,2021,ENSG00000215644,TRUE
Qelbree,Viloxazine,Viloxazine,Supernus,CHEMBL306700,SNRI,ADHD,attention deficit hyperactivity disorder,EFO_0003888,Psychiatric,S,2021,ENSG00000103546,FALSE
Nextstellis,Drospirenone; estetrol,Drospirenone,Mayne Pharma,CHEMBL1509,Spironolactone and oestrogen analogues,To prevent pregnancy,reproductive behaviour measurement,EFO_0007862,Reproductive,S,2021,"ENSG00000151623, ENSG00000082175",TRUE
Nextstellis,Drospirenone; estetrol,estetrol,Mayne Pharma,CHEMBL1230314,Spironolactone and oestrogen analogues,To prevent pregnancy,reproductive behaviour measurement,EFO_0007862,Reproductive,S,2021,"ENSG00000091831, ENSG00000140009",TRUE
Jemperli,Dostarlimab,Dostarlimab,GlaxoSmithKline,CHEMBL4298124,PD1-targeted mAb,Endometrial cancer,endometrial cancer,MONDO_0011962,Oncology,"P, B, A",2021,ENSG00000188389,TRUE
Zynlonta,Loncastuximab tesirine,Loncastuximab tesirine,ADC Therapeutics,CHEMBL4297778,CD19-targeted ADC,B-cell lymphoma,B-cell non-Hodgkins lymphoma,EFO_1001938,Oncology,"P, O, A",2021,ENSG00000177455,TRUE
Empaveli,Pegcetacoplan,Pegcetacoplan,Apellis,CHEMBL4298211,Complement protein C3 inhibitor,PNH,paroxysmal nocturnal hemoglobinuria,MONDO_0100244,Other,"P, O",2021,ENSG00000125730,TRUE
Rybrevant,Amivantamab,Amivantamab,J&J,CHEMBL4297774,EGFRxMETR bispecific antibody,EGFR exon 20-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, B, A",2021,"ENSG00000105976, ENSG00000146648",TRUE
Pylarify,Piflufolastat F-18,Piflufolastat F-18,Progenics,CHEMBL4297334,Radiolabelled PSMA imaging agent,Prostate cancer imaging,prostate carcinoma,EFO_0001663,Imaging,P,2021,ENSG00000086205,FALSE
Truseltiq,Infigratinib,Infigratinib,BridgeBio,CHEMBL1852688,FGFR2 kinase inhibitor,FGFR2-mutated bile duct cancer,bile duct cancer,MONDO_0003059,Oncology,"P, O, A",2021,"ENSG00000160867, ENSG00000068078, ENSG00000066468, ENSG00000077782",TRUE
Lumakras,Sotorasib,Sotorasib,Amgen,CHEMBL4535757,KRAS-G12C inhibitor,KRASG12C-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2021,ENSG00000133703,TRUE
Lybalvi,Olanzapine; samidorphan,samidorphan,Alkermes,CHEMBL426084,Atypical antipsychotic and opioid antagonist,Schizophrenia and bipolar I disorder,Schizophrenia; bipolar I disorder,MONDO_0005090; EFO_0009963,Psychiatric,S,2021,"ENSG00000112038, ENSG00000116329, ENSG00000082556",TRUE
Lybalvi,Olanzapine; samidorphan,Olanzapine,Alkermes,CHEMBL715,Atypical antipsychotic and opioid antagonist,Schizophrenia and bipolar I disorder,Schizophrenia; bipolar I disorder,MONDO_0005090; EFO_0009963,Psychiatric,S,2021,"ENSG00000102468, ENSG00000147246, ENSG00000151577, ENSG00000069696, ENSG00000149295",TRUE
Brexafemme,Ibrexafungerp,Ibrexafungerp,Scynexis,CHEMBL4297513,Triterpenoid antifungal,Vulvovaginal candidiasis,NA,NA,Infectious,P,2021,NA,NA
Aduhelm,Aducanumab,Aducanumab,Biogen/Eisai,CHEMBL3039540,Amyloid-beta-targeted mAb,Alzheimers disease,Alzheimers disease,MONDO_0004975,Other,"P, A",2021,ENSG00000142192,TRUE
Rylaze,Asparaginase erwinia chrysanthemi,Asparaginase erwinia chrysanthemi,Jazz,CHEMBL1863514,Recombinant asparagine-specific enzyme,"ALL and LBL, in patients allergic to E. coli-derived products",acute lymphoblastic leukemia; lymphoblastic lymphoma,EFO_0000220; MONDO_0000873,Oncology,"S, O",2021,NA,NA
Kerendia,Finerenone,Finerenone,Bayer,CHEMBL2181927,Non-steroidal MR antagonist,CKD with type 2 diabetes,chronic kidney disease,EFO_0003884,Other,P,2021,ENSG00000151623,TRUE
Fexinidazole,Fexinidazole,Fexinidazole,Sanofi/DNDi,CHEMBL1631694,Nitroimidazole antimicrobial,Sleeping sickness,NA,NA,Infectious,"P, O",2021,NA,NA
Rezurock,Belumosudil,Belumosudil,Kadmon,CHEMBL2005186,ROCK2 kinase inhibitor,Chronic GVHD,graft versus host disease,MONDO_0013730,Other,"P, O, B",2021,"ENSG00000134318, ENSG00000067900",FALSE
Bylvay,Odevixibat,Odevixibat,Albireo,CHEMBL4297588,IBAT inhibitor,Pruritus in PFIC,familial intrahepatic cholestasis,MONDO_0017290,Other,"P, O",2021,ENSG00000125255,TRUE
Saphnelo,Anifrolumab,Anifrolumab,AstraZeneca,CHEMBL2364653,IFNAR-targeted mAb,SLE,systemic lupus erythematosus,MONDO_0007915,Other,S,2021,ENSG00000142166,TRUE
Nexviazyme,Avalglucosidase alfa,Avalglucosidase alfa,Sanofi,CHEMBL4594320,Recombinant alpha-glucosidase,Pompe disease,glycogen storage disease II,MONDO_0009290,Other,"P, O, B",2021,ENSG00000171298,TRUE
Welireg,Belzutifan,Belzutifan,Merck & Co.,CHEMBL4585668,HIF-2alpha inhibitor,von Hippel-Lindau disease,von Hippel-Lindau disease,MONDO_0008667,Oncology,"P, O",2021,ENSG00000116016,TRUE
Korsuva,Difelikefalin,Difelikefalin,Cara Therapeutics,CHEMBL3989915,kappa-Opioid receptor agonist,Pruritus associated with CKD,chronic kidney disease,EFO_0003884,Other,"P, B",2021,ENSG00000082556,FALSE
Skytrofa,Lonapegsomatropin,Lonapegsomatropin,Ascendis Pharma,CHEMBL4298185,PEGylated human growth hormone,Growth failure due to GHD,Growth delay,HP_0001510,Other,"S, O",2021,ENSG00000112964,TRUE
Exkivity,Mobocertinib,Mobocertinib,Takeda,CHEMBL4650319,EGFR kinase inhibitor,EGFR exon 20-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2021,ENSG00000146648,TRUE
Tivdak,Tisotumab vedotin,Tisotumab vedotin,Seagen/Genmab,CHEMBL4297841,Tissue-factor-directed ADC,Cervical cancer,cervical cancer,MONDO_0002974,Oncology,"P, A",2021,"ENSG00000117525, ENSG00000167552, ENSG00000258947, ENSG00000137267, ENSG00000188229, ENSG00000176014, ENSG00000261456, ENSG00000123416, ENSG00000198033, ENSG00000196230, ENSG00000167553, ENSG00000152086, ENSG00000104833, ENSG00000137285, ENSG00000101162, ENSG00000127824",TRUE
Qulipta,Atogepant,Atogepant,AbbVie,CHEMBL3991065,CGRP receptor antagonist,Episodic migraine,migraine disorder,MONDO_0005277,Other,S,2021,ENSG00000064989,TRUE
Livmarli,Maralixibat,Maralixibat,Mirum,CHEMBL363392,IBAT inhibitor,Pruritus in Alagille syndrome,Alagille syndrome,MONDO_0007318,Other,"P, O, B",2021,ENSG00000125255,TRUE
Tavneos,Avacopan,Avacopan,ChemoCentryx,CHEMBL3989871,Complement 5a receptor antagonist,ANCA-associated vasculitis,Anti-neutrophil cytoplasmic antibody-associated vasculitis,MONDO_0015492,Cardiovascular,"S, O",2021,ENSG00000197405,FALSE
Scemblix,Asciminib,Asciminib,Novartis,CHEMBL4208229,ABL/BCR-ABL1  kinase inhibitor,Ph+ CML,Blast Phase Chronic Myelogenous Leukemia; BCR-ABL1 Positive,EFO_1000131,Oncology,"P, O, B, A",2021,ENSG00000097007,TRUE
Besremi,Ropeginterferon alfa-2b,Ropeginterferon alfa-2b,Pharmaessentia,CHEMBL4297819,PEGylated interferon alpha-2b,Polycythaemia vera,polycythemia vera,EFO_0002429,Oncology,"S, O",2021,"ENSG00000142166, ENSG00000159110",TRUE
Voxzogo,Vosoritide,Vosoritide,Biomarin,CHEMBL3707276,CNP analogue,Achondroplasia,achondroplasia,MONDO_0007037,Other,"P, O, A",2021,ENSG00000159899,TRUE
Livtencity,Maribavir,Maribavir,Takeda,CHEMBL515408,CMV pUL97 kinase inhibitor,Post-transplant CMV infection,NA,NA,Infectious,"P, O, B",2021,NA,NA
Cytalux,Pafolacianine,Pafolacianine,On Target Labs,CHEMBL4297412,Fluorescent FR imaging agent,Ovarian cancer imaging,ovarian carcinoma,EFO_0001075,Imaging,"P, O",2021,ENSG00000110195,FALSE
Vyvgart,Efgartigimod alfa,Efgartigimod alfa,Argenx,CHEMBL4297551,FcRn-binding Fc fragment,Myasthenia gravis,NA,EFO_0004991,Other,"S, O",2021,ENSG00000104870,FALSE
Tezspire,Tezepelumab,Tezepelumab,Astrazeneca/Amgen,CHEMBL3707229,TSLP-targeted mAb,Severe asthma,asthma,MONDO_0004979,Respiratory,P,2021,ENSG00000145777,TRUE
Leqvio,Inclisiran,Inclisiran,Novartis/Alnylam,CHEMBL3990033,PCSK9-targeted siRNA,HeFH or ASCVD,coronary atherosclerosis,MONDO_0021661,Cardiovascular,S,2021,ENSG00000169174,TRUE
Adbry,Tralokinumab,Tralokinumab,LEO Pharma,CHEMBL1743081,IL-13-targeted mAb,Atopic dermatitis,atopic eczema,EFO_0000274,Dermatology,S,2021,ENSG00000169194,TRUE
Cibinqo,Abrocitinib,Abrocitinib,Pfizer,CHEMBL3655081,JAK inhibitor,Atopic dermatitis,"atopic eczema, Eczema",EFO_0000274; HP_0000964,Dermatology,"P, B",2022,"ENSG00000162434, ENSG00000166888",TRUE
Krazati,Adagrasib,Adagrasib,Mirati,CHEMBL4594350,KRAS-G12C inhibitor,KRASG12C-mutated NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"S, O, B, A",2022,ENSG00000133703,TRUE
NexoBrid,Anacaulase,Anacaulase,Mediwound,NA,Proteolytic enzymes from pineapple plants,Eschar removal after thermal burns,NA,NA,Other,"S, O",2022,NA,NA
Quviviq,Daridorexant,Daridorexant,Idorsia,CHEMBL4297590,Orexin receptor antagonist,Insomnia,insomnia,EFO_0004698,Other,S,2022,"ENSG00000137252, ENSG00000121764",TRUE
Daxxify,DaxibotulinumtoxinA,DaxibotulinumtoxinA,Revance,CHEMBL3707359,Botulinum toxin,Glabellar lines,Facial wrinkling,HP_0009762,Other,S,2022,ENSG00000132639,FALSE
Sotyktu,Deucravacitinib,Deucravacitinib,Bristol Myers Squibb,CHEMBL4435170,TYK2 inhibitor,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,Dermatology,S,2022,ENSG00000105397,TRUE
Rolvedon,Eflapegrastim,Eflapegrastim,Spectrum,CHEMBL3833384,Leukocyte growth factor,"Incidence of infection in non-myeloid malignancies, with myelosuppressive drugs",infection,EFO_0000544,Infectious,S,2022,ENSG00000119535,TRUE
Vabysmo,Faricimab,Faricimab,Roche/Genentech,CHEMBL4297750,VEGF _ ANG2 bispecific antibody,nAMD and DME,age-related macular degeneration,EFO_0001365,Ophthalmology,S,2022,"ENSG00000112715, ENSG00000091879",TRUE
Lytgobi,Futibatinib,Futibatinib,Taiho Oncology,CHEMBL3701238,FGFR kinase inhibitor,FGFR2-aberrant intrahepatic cholangiocarcinoma,intrahepatic cholangiocarcinoma,EFO_1001961,Oncology,"P, O, B, A",2022,"ENSG00000068078, ENSG00000077782, ENSG00000160867, ENSG00000066468",TRUE
Elucirem,Gadopiclenol,Gadopiclenol,Guerbet,CHEMBL4297634,Gadolinium-based contrast agent,Lesions with abnormal vascularity,NA,NA,Imaging,P,2022,NA,NA
Ztalmy,Ganaxolone,Ganaxolone,Marinus,CHEMBL1568698,GABAA receptor positive allosteric modulator,Seizures associated with CDD,Epileptic encephalopathy,HP_0200134,Other,"P, O",2022,"ENSG00000094755, ENSG00000163288, ENSG00000102287, ENSG00000166206, ENSG00000145863, ENSG00000022355, ENSG00000113327, ENSG00000187730, ENSG00000011677, ENSG00000268089, ENSG00000145864, ENSG00000151834, ENSG00000186297, ENSG00000182256, ENSG00000109158, ENSG00000163285",TRUE
Sunlenca,Lenacapavir,Lenacapavir,Gilead,CHEMBL4594438,HIV-1 capsid inhibitor,HIV-1 infection,HIV-1 infection,EFO_0000180,Infectious,"P, B",2022,NA,NA
Pluvicto,Lutetium Lu-177 vipivotide tetraxetan,Lutetium Lu-177 vipivotide tetraxetan,Novartis,CHEMBL4594406,PSMA-binding radioligand therapeutic agent,PSMA-positive prostate cancer,prostate carcinoma,EFO_0001663,Oncology,"P, B",2022,ENSG00000142515,TRUE
Camzyos,Mavacamten,Mavacamten,Bristol Myers Squibb,CHEMBL4297517,Cardiac myosin inhibitor,Classes of obstructive HCM (Hypertrophic Obstructive Cardiomyopathy),hypertrophic cardiomyopathy,EFO_0000538,Cardiovascular,"S, O, B",2022,ENSG00000092054,TRUE
Elahere,Mirvetuximab soravtansine,Mirvetuximab soravtansine,ImmunoGen,CHEMBL3545132,FR_-targeted antibody-drug conjugate,Ovarian cancer,ovarian carcinoma,EFO_0001075,Oncology,"P, O, A",2022,"ENSG00000110195, ENSG00000127824, ENSG00000152086, ENSG00000261456, ENSG00000101162, ENSG00000188229, ENSG00000104833, ENSG00000258947, ENSG00000123416, ENSG00000198033, ENSG00000167553, ENSG00000137285, ENSG00000167552, ENSG00000176014, ENSG00000137267, ENSG00000196230",TRUE
Pyrukynd,Mitapivat,Mitapivat,Agios,CHEMBL4299940,Pyruvate kinase activator,Haemolytic anaemia due to PK deficiency,hemolytic anemia,EFO_0005558,Other,"P, O",2022,ENSG00000143627,TRUE
Lunsumio,Mosunetuzumab,Mosunetuzumab,Roche/Genentech,CHEMBL4297788,CD20 _ CD3 bispecific antibody,Follicular lymphoma,follicular lymphoma,MONDO_0018906,Oncology,"P, O, B, A",2022,"ENSG00000167286, ENSG00000156738, ENSG00000198851, ENSG00000160654",TRUE
Xenpozyme,Olipudase alfa,Olipudase alfa,Sanofi/Genzyme,CHEMBL3707358,Acid sphingomyelinase ERT,Acid sphingomyelinase deficiency,acid sphingomyelinase deficiency,MONDO_0100464,Other,"P, O, B",2022,ENSG00000166311,TRUE
Rezlidhia,Olutasidenib,Olutasidenib,Rigel/Forma,CHEMBL4297610,IDH1 inhibitor,IDH1-mutated AML,acute myeloid leukemia,EFO_0000222,Oncology,"S, O",2022,ENSG00000138413,TRUE
Omlonti,Omidenepag isopropyl,Omidenepag isopropyl,Santen,CHEMBL4297666,Prostaglandin E2 receptor agonist,Intraocular pressure in open-angle glaucoma or ocular hypertension,"ocular hypertension, open-angle glaucoma",EFO_1001069; EFO_0004190,Ophthalmology,S,2022,ENSG00000125384,FALSE
Vivjoa,Oteseconazole,Oteseconazole,Mycovia,CHEMBL3311228,Azole antifungal,Vulvovaginal candidiasis,vulvovaginal candidiasis,EFO_0007543,Infectious,P,2022,NA,NA
Vonjo,Pacritinib,Pacritinib,CTI Biopharma,CHEMBL2035187,JAK2 inhibitor,Myelofibrosis,myelofibrosis,MONDO_0044903,Oncology,"P, O, A",2022,"ENSG00000096968, ENSG00000122025",TRUE
Opdualag,Relatlimab; nivolumab,Relatlimab,Bristol Myers Squibb,CHEMBL3990044,LAG3-targeted mAb plus PD1-targeted mAb,Melanoma,melanoma,EFO_0000756,Oncology,"P, O",2022,ENSG00000089692,TRUE
Opdualag,Relatlimab; nivolumab,nivolumab,Bristol Myers Squibb,CHEMBL2108738,LAG3-targeted mAb plus PD1-targeted mAb,Melanoma,melanoma,EFO_0000756,Oncology,"P, O",2022,"ENSG00000188389, ENSG00000120217",TRUE
Relyvrio,Sodium phenylbutyrate; taurursodiol,Sodium phenylbutyrate,Amylyx,CHEMBL1746,Mechanism unknown,Amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,MONDO_0004976,Other,"P, O",2022,NA,NA
Relyvrio,Sodium phenylbutyrate; taurursodiol,taurursodiol,Amylyx,CHEMBL272427,Mechanism unknown,Amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,MONDO_0004976,Other,"P, O",2022,NA,NA
Spevigo,Spesolimab,Spesolimab,Boehringer Ingelheim,CHEMBL4297911,IL-36R-targeted mAb,Generalized pustular psoriasis flares,"psoriasis 14, pustular",MONDO_0013626,Dermatology,"P, O, B",2022,"ENSG00000115598, ENSG00000196083, ENSG00000136695",TRUE
Enjaymo,Sutimlimab,Sutimlimab,Bioverativ,CHEMBL4297832,C1s-targeted mAb,RBC transfusion due to haemolysis in CAD (cold agglutinin disease),"Anemia, Hemolytic, Autoimmune",EFO_1001264,Autoimmune,"P, O, B",2022,ENSG00000182326,FALSE
Vtama,Tapinarof,Tapinarof,Dermavant,CHEMBL259571,Aryl hydrocarbon receptor agonist,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,Dermatology,S,2022,ENSG00000106546,TRUE
Kimmtrak,Tebentafusp,Tebentafusp,Immunocore,CHEMBL4297990,gp100 peptide HLA _ CD3 bispecific T-cell engager,Uveal melanoma,Uveal Melanoma,EFO_1000616,Oncology,"P, O, B",2022,ENSG00000185664,FALSE
Tecvayli,Teclistamab,Teclistamab,J&J,CHEMBL4594505,BCMA _ CD3 bispecific antibody,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O, B, A",2022,"ENSG00000048462, ENSG00000160654, ENSG00000198851, ENSG00000167286",TRUE
Tzield,Teplizumab,Teplizumab,Provention Bio,CHEMBL1743078,CD3-targeted antibody,Delay onset of type 1 diabetes,type 1 diabetes mellitus,MONDO_0005147,Autoimmune,"P, B",2022,"ENSG00000198851, ENSG00000081237, ENSG00000198821",TRUE
Terlivaz,Terlipressin,Terlipressin,Mallinckrodt,CHEMBL2135460,Vasopressin receptor agonist,Kidney function in hepatorenal syndrome,Hepatorenal syndrome,MONDO_0001382,Other,"P, O",2022,ENSG00000166148,FALSE
Mounjaro,Tirzepatide,Tirzepatide,Eli Lilly,CHEMBL4297839,GIP receptor and GLP1 receptor agonist,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Autoimmune,S,2022,"ENSG00000010310, ENSG00000112164",TRUE
Imjudo,Tremelimumab,Tremelimumab,AstraZeneca,CHEMBL2108658,CTLA4-targeted mAb,Hepatocellular carcinoma,hepatocellular carcinoma,EFO_0000182,Oncology,"S, O",2022,ENSG00000163599,TRUE
Briumvi,Ublituximab,Ublituximab,TG Therapeutics,CHEMBL2108354,CD20-targeted mAb,Relapsing forms of multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,Other,S,2022,ENSG00000156738,FALSE
Voquezna Triple Pak,Vonoprazan; amoxicillin; clarithromycin,Vonoprazan,Phathom,CHEMBL2079130,Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial,Helicobacter pylori infection,Helicobacter pylori infectious disease,EFO_1000961,Infectious,P,2022,"ENSG00000186009, ENSG00000105675",NA
Voquezna Triple Pak,Vonoprazan; amoxicillin; clarithromycin,amoxicillin,Phathom,CHEMBL1082,Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial,Helicobacter pylori infection,Helicobacter pylori infectious disease,EFO_1000961,Infectious,P,2022,NA,NA
Voquezna Triple Pak,Vonoprazan; amoxicillin; clarithromycin,clarithromycin,Phathom,CHEMBL1741,Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial,Helicobacter pylori infection,Helicobacter pylori infectious disease,EFO_1000961,Infectious,P,2022,NA,NA
Amvuttra,Vutrisiran,Vutrisiran,Alnylam,CHEMBL4594511,TTR-targeted siRNA,Polyneuropathy of hereditary TTR-mediated amyloidosis,familial amyloid neuropathy,EFO_0004129,Other,"S, O",2022,ENSG00000118271,TRUE
Xenoview,Xenon Xe 129 hyperpolarized,Xenon Xe 129 hyperpolarized,Polarean,CHEMBL4594411,Hyperpolarized contrast agent,MRI-evaluation of lung ventilation,NA,NA,Imaging,S,2022,NA,NA
Trulance,Plecanatide,PLECANATIDE,Synergy Pharmaceuticals,CHEMBL2103867,Guanylate cyclase C agonist,Chronic idiopathic constipation,Chronic constipation,HP_0012450,Gastrointestinal,S,2017,ENSG00000070019,FALSE
Parsabiv,Etelcalcetide,VELCALCETIDE,Amgen/Kai Pharmaceuticals,CHEMBL3545184,Calcium-sensing receptor agonist,Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis,hyperparathyroidism,EFO_0008506,Nephrology,S,2017,ENSG00000036828,TRUE
Emflaza,Deflazacort,DEFLAZACORT,PTC Therapeutics,CHEMBL1201891,Corticosteroid,Duchenne muscular dystrophy,Duchenne muscular dystrophy,MONDO_0010679,Neurological,"P, O",2017,ENSG00000113580,FALSE
Siliq,Brodalumab,BRODALUMAB,Valeant Pharmaceuticals,CHEMBL1742996,IL-17RA antagonist,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,Dermatology,S,2017,ENSG00000177663,TRUE
Xermelo,Telotristat etiprate,TELOTRISTAT ETIPRATE,Lexicon Pharmaceuticals,CHEMBL3348963,Tryptophan hydroxylase inhibitor,Carcinoid syndrome diarrhoea,carcinoid syndrome; Diarrhea,EFO_1000852; HP_0002014,Gastrointestinal,"P, O",2017,"ENSG00000129167, ENSG00000139287",FALSE
Kisqali,Ribociclib,RIBOCICLIB,Novartis,CHEMBL3545110,CDK4/6 inhibitor,"HR-positive, HER2-negative breast cancer",HER2 negative breast carcinoma,EFO_0009780,Oncology,"P, B",2017,"ENSG00000105810, ENSG00000135446",TRUE
Xadago,Safinamide,SAFINAMIDE,US WorldMeds,CHEMBL396778,MAO-B inhibitor,Parkinson disease,Parkinson disease,MONDO_0005180,Neurological,S,2017,ENSG00000069535,TRUE
Symproic,Naldemedine,NALDEMEDINE,Shionogi,CHEMBL2105755,Opioid antagonist,Opioid-induced constipation,Constipation,HP_0002019,Gastrointestinal,S,2017,ENSG00000112038,FALSE
Bavencio,Avelumab,AVELUMAB,Merck KGaA/Pfizer,CHEMBL3833373,PDL1-blocking antibody,Merkel cell carcinoma,Merkel cell skin cancer,EFO_1001471,Oncology,"P, O, B, A",2017,ENSG00000120217,TRUE
Zejula,Niraparib,NIRAPARIB,Tesaro,CHEMBL1094636,PARP inhibitor,"Epithelial ovarian, fallopian tube or primary peritoneal cancer",fallopian tube cancer; ovarian epithelial tumor; primary peritoneal carcinoma,MONDO_0002158; MONDO_0002229; MONDO_0015686,Oncology,"P, O, B",2017,"ENSG00000129484, ENSG00000143799",TRUE
Ocrevus,Ocrelizumab,OCRELIZUMAB,Roche/Genentech,CHEMBL2108041,CD20-directed cytolytic antibody,Relapsing or primary progressive forms of multiple sclerosis,chronic progressive multiple sclerosis,EFO_0003840,Neurological,"P, B",2017,ENSG00000156738,FALSE
Dupixent,Dupilumab,DUPILUMAB,Regeneron/Sanofi,CHEMBL2108675,IL-4Ralpha antagonist,Atopic dermatitis,atopic eczema,EFO_0000274,Dermatology,"P, B",2017,ENSG00000077238,TRUE
Austedo,Deutetrabenazine,DUTETRABENAZINE,Teva,CHEMBL3137326,VMAT2 inhibitor,Chorea associated with Huntington disease,chorea; Huntington disease,EFO_0004152; MONDO_0007739,Neurological,"S, O",2017,ENSG00000165646,TRUE
Ingrezza,Valbenazine,VALBENAZINE,Neurocrine Biosciences,CHEMBL2364639,VMAT2 inhibitor,Tardive dyskinesia,movement disorder,EFO_0004280,Neurological/Psychiatric,"P, B",2017,ENSG00000165646,TRUE
Brineura,Cerliponase alfa,CERLIPONASE ALFA,BioMarin Pharmaceutical,CHEMBL3544921,Tripeptidyl peptidase,Tripeptidyl peptidase 1 deficiency (neuronal ceroid lipofuscinosis type 2*),neuronal ceroid lipofuscinosis 2,MONDO_0008769,Neurological,"P, O, B",2017,ENSG00000166340,TRUE
Rydapt,Midostaurin,MIDOSTAURIN,Novartis,CHEMBL608533,FLT3 inhibitor,FLT3-positive AML,"acute myeloid leukemia, FLT3 internal tandem duplication",MONDO_0100415,Oncology,"P, O, B",2017,"ENSG00000163932, ENSG00000115825, ENSG00000166501, ENSG00000171132, ENSG00000163558, ENSG00000184304, ENSG00000065675, ENSG00000126583, ENSG00000027075, ENSG00000067606, ENSG00000154229, ENSG00000128052, ENSG00000122025, ENSG00000157404, ENSG00000134853, ENSG00000113721",TRUE
Tymlos,Abaloparatide,ABALOPARATIDE,Radius Health,CHEMBL3301581,Parathyroid hormone-related protein,Osteoporosis,osteoporosis,EFO_0003882,Endocrine,S,2017,ENSG00000160801,TRUE
Alunbrig,Brigatinib,BRIGATINIB,Ariad Pharmaceuticals/Takeda,CHEMBL3545311,ALK inhibitor,ALK-positive NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2017,"ENSG00000171094, ENSG00000146648",TRUE
Imfinzi,Durvalumab,DURVALUMAB,AstraZeneca,CHEMBL3301587,PDL1-blocking antibody,Urothelial carcinoma,urothelial carcinoma,EFO_0008528,Oncology,"P, B, A",2017,ENSG00000120217,TRUE
Radicava,Edaravone,EDARAVONE,Mitsubishi Tanabe,CHEMBL290916,Unknown (radical scavenger),ALS (amyotrophic lateral sclerosis),amyotrophic lateral sclerosis,MONDO_0004976,Neurological,"S, O",2017,NA,NA
Kevzara,Sarilumab,SARILUMAB,Sanofi/Regeneron,CHEMBL2108730,IL-6 receptor antagonist,Rheumatoid arthritis,rheumatoid arthritis,EFO_0000685,Autoimmune,S,2017,ENSG00000160712,TRUE
Baxdela,Delafloxacin,DELAFLOXACIN,Melinta Therapeutics,CHEMBL2105637,Fluoroquinolone antibacterial,Acute bacterial skin and skin structure infections,staphylococcal skin infections,EFO_1001849,Infectious,P,2017,NA,NA
Bevyxxa,Betrixaban,BETRIXABAN,Portola Pharmaceuticals,CHEMBL512351,FXa inhibitor,Prophylaxis of venous thromboembolism,venous thromboembolism,EFO_0004286,Cardiovascular,P,2017,ENSG00000126218,TRUE
Tremfya,Guselkumab,GUSELKUMAB,Janssen/Johnson & Johnson,CHEMBL2364648,IL-23 blocker,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,Dermatology,P,2017,"ENSG00000113302, ENSG00000110944",TRUE
Nerlynx,Neratinib,NERATINIB,Puma Biotechnology,CHEMBL180022,"EGFR, HER2 and HER4 irreversible kinase inhibitor",HER2-overexpressed breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,Oncology,S,2017,"ENSG00000178568, ENSG00000146648, ENSG00000141736",TRUE
Vosevi,Sofosbuvir; velpatasvir; voxilaprevir,SOFOSBUVIR,Gilead Sciences,CHEMBL1259059,Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor,HCV,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2017,NA,NA
Vosevi,Sofosbuvir; velpatasvir; voxilaprevir,VELPATASVIR,Gilead Sciences,CHEMBL3545062,Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor,HCV,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2017,NA,NA
Vosevi,Sofosbuvir; velpatasvir; voxilaprevir,VOXILAPREVIR,Gilead Sciences,CHEMBL3707372,Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor,HCV,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2017,NA,NA
Idhifa,Enasidenib mesylate,ENASIDENIB MESYLATE,Celgene/Agios,CHEMBL3989931,IDH2 inhibitor,IDH2-mutated AML,acute myeloid leukemia,EFO_0000222,Oncology,"P, O",2017,ENSG00000182054,TRUE
Mavyret,Glecaprevir; pibrentasvir,GLECAPREVIR,AbbVie,CHEMBL3545363,NS3/4A protease inhibitor plus a NS5A inhibitor,HCV,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2017,NA,NA
Mavyret,Glecaprevir; pibrentasvir,PIBRENTASVIR,AbbVie,CHEMBL3545123,NS3/4A protease inhibitor plus a NS5A inhibitor,HCV,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2017,NA,NA
Besponsa,Inotuzumab ozogamicin,INOTUZUMAB OZOGAMICIN,Pfizer,CHEMBL2108611,CD22-directed antibody‚Äö√Ñ√¨drug conjugate,B cell precursor ALL,precursor B-cell acute lymphoblastic leukemia,MONDO_0020511,Oncology,"P, O, B",2017,ENSG00000012124,TRUE
Benznidazole,Benznidazole,BENZNIDAZOLE,Chemo Research,CHEMBL110,Nitroimidazole antimicrobial,Chagas disease,Chagas disease,MONDO_0001444,Infectious,"P, O, A",2017,NA,NA
Vabomere,Meropenem; vaborbactam,MEROPENEM,The Medicines Company/Rempex Pharmaceuticals,CHEMBL127,Carbapenem antimicrobial plus a ≈í‚â§-lactamase inhibitor,Complicated urinary tract infections,urinary tract infection,EFO_0003103,Infectious,P,2017,NA,NA
Vabomere,Meropenem; vaborbactam,VABORBACTAM,The Medicines Company/Rempex Pharmaceuticals,CHEMBL3317857,Carbapenem antimicrobial plus a ≈í‚â§-lactamase inhibitor,Complicated urinary tract infections,urinary tract infection,EFO_0003103,Infectious,P,2017,NA,NA
Aliqopa,Copanlisib dihydrochloride,COPANLISIB,Bayer,CHEMBL3218576,PI3Kalpha/≈í¬• inhibitor,Follicular lymphoma,follicular lymphoma,MONDO_0018906,Oncology,"P, O, A",2017,"ENSG00000171608, ENSG00000121879",TRUE
Solosec,Secnidazole,SECNIDAZOLE,Lupin,CHEMBL498847,Nitroimidazole antimicrobial,Bacterial vaginosis,bacterial vaginosis,EFO_0003932,Infectious,P,2017,NA,NA
Verzenio,Abemaciclib,ABEMACICLIB,Eli Lilly,CHEMBL3301610,CDK4/6 inhibitor,"HR-positive, HER2-negative breast cancer",HER2 negative breast carcinoma,EFO_0009780,Oncology,"P, B",2017,"ENSG00000105810, ENSG00000135446",TRUE
Calquence,Acalabrutinib,ACALABRUTINIB,AstraZeneca/Acerta Pharma,CHEMBL3707348,BTK inhibitor,Mantle cell lymphoma,Mantle cell lymphoma,EFO_1001469,Oncology,"P, O, B, A",2017,ENSG00000010671,TRUE
Vyzulta,Latanoprostene bunod,LATANOPROSTENE BUNOD,Bausch and Lomb/Valeant Pharmaceuticals,CHEMBL2364612,Prostaglandin analogue,Intraocular pressure,intraocular pressure measurement,EFO_0004695,Ophthalmology,S,2017,ENSG00000122420,FALSE
Prevymis,Letermovir,LETERMOVIR,Merck & Co.,CHEMBL1241951,CMV DNA terminase complex inhibitor,Prophylaxis of CMV (cytomegalovirus),cytomegalovirus infection,EFO_0001062,Infectious,"P, O, B",2017,NA,NA
Fasenra,Benralizumab,BENRALIZUMAB,AstraZeneca,CHEMBL1742991,IL-5Ralpha-directed monoclonal antibody,Severe asthma,Status Asthmaticus,EFO_0008590,Respiratory,S,2017,ENSG00000091181,FALSE
Mepsevii,Vestronidase alfa,VESTRONIDASE ALFA,Ultragenyx,CHEMBL3707382,Recombinant human lysosomal ≈í‚â§-glucuronidase,Mucopolysaccharidosis VII,mucopolysaccharidosis type 7,MONDO_0009662,Metabolic,"P, O",2017,ENSG00000169919,TRUE
Hemlibra,Emicizumab,EMICIZUMAB,Roche/Genentech,CHEMBL3833393,Bispecific FIX and FX-directed antibody,Haemophilia A,hemophilia A,MONDO_0010602,Hematology,"P, O, B",2017,"ENSG00000126218, ENSG00000101981",TRUE
Ozempic,Semaglutide,SEMAGLUTIDE,Novo Nordisk,CHEMBL2108724,GLP1 receptor agonist,Type 2 diabetes mellitus,type 2 diabetes mellitus,MONDO_0005148,Endocrine,S,2017,ENSG00000112164,TRUE
Xepi,Ozenoxacin,OZENOXACIN,Ferrer Internacional,CHEMBL3990047,Quinolone antimicrobial,Impetigo due to Staphylococcus aureus or Streptococcus pyogenes,impetigo,EFO_1000714,Infectious,S,2017,NA,NA
Rhopressa,Netarsudil,NETARSUDIL,Aerie Pharmaceuticals,CHEMBL4594250,RHO kinase inhibitor,Open-angle glaucoma or ocular hypertension,open-angle glaucoma; ocular hypertension,EFO_0004190; EFO_1001069,Ophthalmology,P,2017,"ENSG00000134318, ENSG00000067900",FALSE
Steglatro,Ertugliflozin,ERTUGLIFLOZIN,Merck & Co./Pfizer,CHEMBL1770248,SGLT2 inhibitor,Type 2 diabetes mellitus,type 2 diabetes mellitus,MONDO_0005148,Endocrine,S,2017,ENSG00000140675,TRUE
Macrilen,Macimorelin,MACIMORELIN,Aeterna Zentaris,CHEMBL278623,Growth hormone secretagogue receptor agonist,Diagnosis of adult growth hormone deficiency,short stature due to GHSR deficiency,MONDO_0014403,Endocrine,"S, O",2017,ENSG00000121853,TRUE
Giapreza,Angiotensin II,ANGIOTENSIN II,La Jolla Pharmaceutical Company,CHEMBL408403,Synthetic human angiotensin,Blood pressure in adults with septic or other distributive shock,septic shock; blood pressure,EFO_0006834; EFO_0004325,Cardiovascular,P,2017,ENSG00000144891,TRUE
Zepatier,Elbasvir; grazoprevir,ELBASVIR,Merck & Co.,CHEMBL3039514,NS5A inhibitor plus NS3/4A protease inhibitor,HCV genotypes 1 and 4,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2016,NA,NA
Zepatier,Elbasvir; grazoprevir,GRAZOPREVIR,Merck & Co.,CHEMBL2063090,NS5A inhibitor plus NS3/4A protease inhibitor,HCV genotypes 1 and 4,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2016,NA,NA
Briviact,Brivaracetam,BRIVARACETAM,UCB,CHEMBL607400,"Anticonvulsant with unknown MOA, binds to SV2A",Partial-onset seizures,Focal-onset seizure,HP_0007359,Neurological,S,2016,"ENSG00000159164, ENSG00000144285",TRUE
Anthim,Obiltoxaximab,OBILTOXAXIMAB,Elusys Therapeutics,CHEMBL3544926,mAb against anthrax toxin,Anthrax,anthrax infection,EFO_0000778,Infectious,"S, O",2016,NA,NA
Taltz,Ixekizumab,IXEKIZUMAB,Eli Lilly,CHEMBL1743034,IL-17A antagonist,Plaque psoriasis,psoriasis vulgaris,EFO_1001494,Dermatology,S,2016,ENSG00000112115,FALSE
Cinqair,Reslizumab,RESLIZUMAB,Teva,CHEMBL2107884,IL-5 antagonist,Severe asthma,Status Asthmaticus,EFO_0008590,Respiratory,S,2016,ENSG00000113525,TRUE
Defitelio,Defibrotide sodium,DEFIBROTIDE SODIUM,Gentium,CHEMBL3707226,Profibrinolytic,Hepatic veno-occlusive disease,hepatic veno-occlusive disease,MONDO_0019514,Other,"P, O",2016,ENSG00000122194,TRUE
Venclexta,Venetoclax,VENETOCLAX,AbbVie,CHEMBL3137309,BCL-2 inhibitor,Chronic lymphocytic leukaemia,chronic lymphocytic leukemia,EFO_0000095,Oncology,"P, O, B, A",2016,ENSG00000171791,TRUE
Nuplazid,Pimavanserin,PIMAVANSERIN,Acadia Pharmaceuticals,CHEMBL2111101,Atypical antipsychotic,Hallucinations and delusions associated with Parkinson disease psychosis,Parkinson disease; psychosis,MONDO_0005180; EFO_0005407,Neurological,"P, B",2016,ENSG00000102468,TRUE
Tecentriq,Atezolizumab,ATEZOLIZUMAB,Genentech,CHEMBL3707227,PDL1 inhibitor,Urothelial carcinoma,urothelial carcinoma,EFO_0008528,Oncology,"P, B, A",2016,ENSG00000120217,TRUE
Ocaliva,Obeticholic acid,OBETICHOLIC ACID,Intercept,CHEMBL566315,FXR agonist,Primary biliary cholangitis,primary biliary cirrhosis,EFO_1001486,Immunology,"P, O, A",2016,ENSG00000012504,TRUE
Axumin,Fluciclovine F-18,FLUCICLOVINE F-18,Blue Earth,CHEMBL3707267,Radioactive diagnostic,Suspected prostate cancer recurrence,prostate cancer,MONDO_0008315,Imaging,P,2016,"ENSG00000155465, ENSG00000105281, ENSG00000165349",TRUE
Zinbryta,Daclizumab,DACLIZUMAB,Biogen,CHEMBL1201605,IL-2-targeted mAb,Multiple sclerosis,multiple sclerosis,MONDO_0005301,Neurological,S,2016,"ENSG00000134460, ENSG00000100385, ENSG00000147168",TRUE
Netspot,Gallium Ga-68 dotatate,GALLIUM GA-68 DOTATATE,Advanced Accelerator Applications,CHEMBL4297340,Radioactive diagnostic,Neuroendocrine tumours,neuroendocrine neoplasm,EFO_1001901,Imaging,"P, O",2016,ENSG00000180616,TRUE
Epclusa,Sofosbuvir; velpatasvir,SOFOSBUVIR,Gilead Sciences,CHEMBL1259059,A nucleotide analogue NS5B polymerase inhibitor plus an HCV NS5A inhibitor,"genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV)",hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2016,NA,NA
Epclusa,Sofosbuvir; velpatasvir,VELPATASVIR,Gilead Sciences,CHEMBL3545062,A nucleotide analogue NS5B polymerase inhibitor plus an HCV NS5A inhibitor,"genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV)",hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2016,NA,NA
Xiidra,Lifitegrast,LIFITEGRAST,Shire Pharmaceuticals,CHEMBL2048028,LFA1 antagonist,Dry eye disease,dry eye syndrome,EFO_1000906,Ophthalmology,P,2016,"ENSG00000160255, ENSG00000005844",FALSE
Adlyxin,Lixisenatide,LIXISENATIDE,Sanofi,CHEMBL2108336,GLP1 receptor agonist,Diabetes,diabetes mellitus,EFO_0000400,Endocrine,S,2016,ENSG00000112164,TRUE
Exondys 51,Eteplirsen,ETEPLIRSEN,Sarepta Therapeutics,CHEMBL2108278,ASO designed to target dystrophin pre-mRNA,Duchenne muscular dystrophy,Duchenne muscular dystrophy,MONDO_0010679,Neurological,"P, O, A",2016,ENSG00000198947,TRUE
Lartruvo,Olaratumab,OLARATUMAB,Eli Lilly,CHEMBL1743049,PDGFRalpha-blocking antibody,Soft tissue sarcoma,soft tissue sarcoma,EFO_1001968,Oncology,"P, O, B, A",2016,ENSG00000134853,TRUE
Zinplava,Bezlotoxumab,BEZLOTOXUMAB,Merck & Co.,CHEMBL2108670,mAb against Clostridium difficile toxin,C. difficile recurrence,clostridium difficile infection,EFO_0009130,"Gastrointestinal, infectious",P,2016,NA,NA
Eucrisa,Crisaborole,CRISABOROLE,Pfizer/Anacor Pharmaceuticals,CHEMBL484785,PDE4 inhibitor,Atopic dermatitis,atopic eczema,EFO_0000274,Dermatology,S,2016,"ENSG00000184588, ENSG00000113448, ENSG00000065989, ENSG00000105650",TRUE
Rubraca,Rucaparib,RUCAPARIB,Clovis Oncology,CHEMBL1173055,PARP inhibitor,BRCA-positive ovarian cancer,ovarian cancer,MONDO_0008170,Oncology,"P, O, B, A",2016,"ENSG00000041880, ENSG00000129484, ENSG00000143799",TRUE
Spinraza,Nusinersen,NUSINERSEN,Biogen/Ionis Pharmaceuticals,CHEMBL3301572,ASO designed to target SMN2 pre-mRNA,Spinal muscular atrophy,spinal muscular atrophy,EFO_0008525,Neurological,"P, O",2016,ENSG00000205571,TRUE
Farxiga,Dapagliflozin,DAPAGLIFLOZIN,AstraZeneca,CHEMBL429910,SGLT2 inhibitor,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Metabolic,S,2014,ENSG00000140675,TRUE
Hetlioz,Tasimelteon,TASIMELTEON,Vanda,CHEMBL2103822,Melatonin-receptor agonist,Non-24-hour sleep-wake disorder,sleep-wake disorder,MONDO_0003406,Neurological,"P, O",2014,"ENSG00000134640, ENSG00000168412",TRUE
Vimizim,Elosulfase alfa,ELOSULFASE ALFA,BioMarin,CHEMBL2108676,Hydrolytic lysosomal glycosaminoglycan-specific enzyme,Mucopolysaccharidosis type IVA,mucopolysaccharidosis type 4A,MONDO_0009659,Metabolic,"P, O",2014,ENSG00000141012,TRUE
Northera,Droxidopa,DROXIDOPA,Lundbeck,CHEMBL2103827,Synthetic amino-acid precursor of noradrenaline; MOA unknown,Light-headedness in patients with neurogenic orthostatic hypotension,primary orthostatic hypotension,MONDO_0015914,Neurological,"P, O, A",2014,"ENSG00000169252, ENSG00000170214, ENSG00000043591, ENSG00000120907, ENSG00000274286, ENSG00000184160, ENSG00000188778, ENSG00000150594, ENSG00000171873",TRUE
Myalept,Metreleptin,METRELEPTIN,Amylin,CHEMBL2107857,Leptin analogue,Leptin deficiency in patients with congenital or acquired generalized lipodystrophy,congenital generalized lipodystrophy,EFO_1000681,Endocrine,"P, O",2014,ENSG00000116678,TRUE
Neuraceq,Florbetaben-F18,FLORBETABEN-F18,Piramal Imaging,CHEMBL566752,Radioactive diagnostic agent,Imaging of the brain to estimate density of neuritic amyloid-beta plaques,neuritic plaque measurement; Alzheimer disease,EFO_0006798; MONDO_0004975,Imaging,S,2014,ENSG00000142192,TRUE
Impavido,Miltefosine,MILTEFOSINE,Knight,CHEMBL125,MOA unknown,Leishmaniasis,Leishmaniasis,EFO_0005044,Infectious,"P, O",2014,NA,NA
Otezla,Apremilast,APREMILAST,Celgene,CHEMBL514800,Phosphodiesterase 4 inhibitor,Psoriatic arthritis and plaque psoriasis,psoriatic arthritis; psoriasis vulgaris,EFO_0003778; EFO_1001494,Dermatology,S,2014,"ENSG00000184588, ENSG00000065989, ENSG00000105650, ENSG00000113448",TRUE
Tanzeum,Albiglutide,ALBIGLUTIDE,GlaxoSmithKline,CHEMBL2107841,GLP1-receptor agonist,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Metabolic,S,2014,ENSG00000112164,TRUE
Cyramza,Ramucirumab,RAMUCIRUMAB,Eli Lilly,CHEMBL1743062,VEGFR2 antagonist,Gastric cancer,gastric cancer,MONDO_0001056,Oncology,"P, O",2014,ENSG00000128052,TRUE
Sylvant,Siltuximab,SILTUXIMAB,Janssen Biotech,CHEMBL1743070,IL-6-specific antibody,Multicentric Castleman's disease,Castleman disease,MONDO_0015564,Other,"P, O",2014,ENSG00000136244,TRUE
Zykadia,Ceritinib,CERITINIB,Novartis,CHEMBL2403108,"Kinase inhibitor against ALK, IGF1R, insulin receptor and ROS1",ALK-positive metastatic NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2014,"ENSG00000171094, ENSG00000143924, ENSG00000181163",TRUE
Zontivity,Vorapaxar,VORAPAXAR,Merck & Co.,CHEMBL493982,Protease-activated receptor 1 antagonist,Thrombotic cardiovascular events (after myocardial infarction or with peripheral arterial disease*),myocardial infarction; peripheral arterial disease,EFO_0000612; EFO_0004265,Cardiovascular,S,2014,ENSG00000181104,FALSE
Entyvio,Vedolizumab,VEDOLIZUMAB,Takeda,CHEMBL1743087,Integrin-receptor antagonist,Ulcerative colitis and Crohn's disease,ulcerative colitis; Crohn's disease,EFO_0000729; EFO_0000384,Gastrointestinal,P,2014,"ENSG00000115232, ENSG00000139626",TRUE
Dalvance,Dalbavancin,DALBAVANCIN,Durata,CHEMBL3301669,Semisynthetic lipoglycopeptide,ABSSSI (Acute Bacterial Skin and Skin Structure Infections),staphylococcal skin infections,EFO_1001849,Infectious,P,2014,NA,NA
Jublia,Efinaconazole,EFINACONAZOLE,Dow,CHEMBL2103877,Azole antifungal,Onychomycosis of the toenails,paronychia,EFO_0007421,"Dermatology, infectious",S,2014,NA,NA
Sivextro,Tedizolid,TEDIZOLID,Cubist,CHEMBL1257051,Oxazolidinone-class antibacterial,ABSSSI (Acute Bacterial Skin and Skin Structure Infections),staphylococcal skin infections,EFO_1001849,Infectious,P,2014,NA,NA
Beleodaq,Belinostat,BELINOSTAT,Spectrum,CHEMBL408513,Histone-deacetylase inhibitor,Peripheral T-cell lymphoma,unspecified peripheral T-cell lymphoma,EFO_0000211,Hematology,"P, O, A",2014,"ENSG00000108840, ENSG00000147099, ENSG00000061273, ENSG00000068024, ENSG00000171720, ENSG00000094631, ENSG00000163517, ENSG00000048052, ENSG00000100429, ENSG00000196591, ENSG00000116478",TRUE
Kerydin,Tavaborole,TAVABOROLE,Anacor,CHEMBL443052,Oxaborole antifungal,Onychomycosis of the toenails,paronychia,EFO_0007421,"Dermatology, infectious",S,2014,NA,NA
Zydelig,Idelalisib,IDELALISIB,Gilead Sciences,CHEMBL2216870,PI3K�p110-delta subunit inhibitor,"CLL, B-cell non-Hodgkin lymphoma and SLL",chronic lymphocytic leukemia; B-cell non-Hodgkins lymphoma,EFO_0000095; EFO_1001938,Hematology,"P, O, B, A",2014,ENSG00000171608,TRUE
Striverdi Respimat,Olodaterol,OLODATEROL,Boehringer Ingelheim,CHEMBL605846,Long-acting beta2-adrenoceptor agonist,COPD,chronic obstructive pulmonary disease,EFO_0000341,Respiratory,S,2014,ENSG00000169252,TRUE
Jardiance,Empagliflozin,EMPAGLIFLOZIN,Boehringer Ingelheim,CHEMBL2107830,SGLT2 inhibitor,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Metabolic,S,2014,ENSG00000140675,TRUE
Orbactiv,Oritavancin,ORITAVANCIN,The Medicines Company,CHEMBL1688530,Semi-synthetic lipoglycopeptide,ABSSSI (Acute Bacterial Skin and Skin Structure Infections),staphylococcal skin infections,EFO_1001849,Infectious,P,2014,NA,NA
Belsomra,Suvorexant,SUVOREXANT,Merck & Co.,CHEMBL1083659,Orexin-receptor antagonist,Insomnia,insomnia,EFO_0004698,Mental health,S,2014,"ENSG00000137252, ENSG00000121764",TRUE
Plegridy,Peginterferon beta-1A,PEGINTERFERON BETA-1A,Biogen Idec,CHEMBL2108677,Long-acting interferon-beta1A,Relapsing multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,Neurological,S,2014,"ENSG00000159110, ENSG00000142166",FALSE
Cerdelga,Eliglustat,ELIGLUSTAT,Genzyme,CHEMBL2110588,Glucosylceramide-synthase inhibitor,Gaucher's disease,Gaucher disease,MONDO_0018150,Metabolic,"P, O",2014,ENSG00000148154,FALSE
Keytruda,Pembrolizumab,PEMBROLIZUMAB,Merck & Co.,CHEMBL3137343,PD1-specific antibody,Metastatic melanoma *and others (2021 approval),metastatic melanoma,EFO_0002617,Oncology,"P, O, B, A",2014,"ENSG00000188389, ENSG00000120217",TRUE
Movantik,Naloxegol,NALOXEGOL,AstraZeneca,CHEMBL2219418,Opioid-receptor antagonist,Opioid-induced constipation,Constipation,HP_0002019,Gastrointestinal,S,2014,ENSG00000112038,FALSE
Trulicity,Dulaglutide,DULAGLUTIDE,Eli Lilly,CHEMBL2108027,GLP1-receptor agonist,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Metabolic,S,2014,ENSG00000112164,TRUE
Lumason,Sulfur hexafluoride lipid-type A microspheres,SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES,Bracco,NA,Ultrasound contrast agent,Cardiovascular imaging,NA,NA,Imaging,S,2014,NA,NA
Akynzeo,Netupitant; palonosetron,NETUPITANT,Helsinn,CHEMBL206253,An NK1-receptor antagonist plus a 5-HT3-receptor antagonist,Chemotherapy-related nausea,Chemotherapy-induced nausea and vomiting,EFO_0006911,Other,S,2014,ENSG00000115353,FALSE
Akynzeo,Netupitant; palonosetron,PALONOSETRON,Helsinn,CHEMBL1189679,An NK1-receptor antagonist plus a 5-HT3-receptor antagonist,Chemotherapy-related nausea,Chemotherapy-induced nausea and vomiting,EFO_0006911,Other,S,2014,ENSG00000166736,FALSE
Harvoni,Ledipasvir; sofosbuvir,LEDIPASVIR,Gilead Sciences,CHEMBL2374220,An NS5A inhibitor plus an HCV nucleotide-analogue NS5B-polymerase inhibitor,Genotype 1 HCV,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2014,NA,NA
Harvoni,Ledipasvir; sofosbuvir,SOFOSBUVIR,Gilead Sciences,CHEMBL1259059,An NS5A inhibitor plus an HCV nucleotide-analogue NS5B-polymerase inhibitor,Genotype 1 HCV,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2014,NA,NA
Esbriet,Pirfenidone,PIRFENIDONE,InterMune,CHEMBL1256391,MOA unknown,IPF (idiopathic pulmonary fibrosis),idiopathic pulmonary fibrosis,EFO_0000768,Respiratory,"P, O, B",2014,NA,NA
Ofev,Nintedanib,NINTEDANIB,Boehringer Ingelheim,CHEMBL502835,"Kinase inhibitor against PDGFRs, FGFRs, VEGFRs and FLT3",IPF (idiopathic pulmonary fibrosis),idiopathic pulmonary fibrosis,EFO_0000768,Respiratory,"P, O, B",2014,"ENSG00000102755, ENSG00000037280, ENSG00000128052, ENSG00000066468, ENSG00000077782, ENSG00000160867, ENSG00000134853, ENSG00000113721, ENSG00000068078",TRUE
Blincyto,Blinatumomab,BLINATUMOMAB,Amgen,CHEMBL1742992,CD19- and CD3-bispecific antibody,B-ALL,precursor B-cell acute lymphoblastic leukemia,MONDO_0020511,Oncology,"P, O, B, A",2014,"ENSG00000177455, ENSG00000160654, ENSG00000167286, ENSG00000198851",TRUE
Xtoro,Finafloxacin,FINAFLOXACIN,Alcon,CHEMBL1908370,Fluoroquinolone antimicrobial,Acute otitis externa (swimmer's ear),otitis externa,EFO_0009560,"Otolaryngology, infectious",P,2014,NA,NA
Lynparza,Olaparib,OLAPARIB,AstraZeneca,CHEMBL521686,PARP inhibitor,Advanced BRCA-mutated ovarian cancer,ovarian cancer,MONDO_0008170,Oncology,"P, O, A",2014,"ENSG00000143799, ENSG00000041880, ENSG00000129484",TRUE
Viekira Pak,Ombitasvir; paritaprevir; dasabuvir; ritonavir,OMBITASVIR,AbbVie,CHEMBL3127326,An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor,Chronic HCV genotype 1 infection,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2014,NA,NA
Viekira Pak,Ombitasvir; paritaprevir; dasabuvir; ritonavir,PARITAPREVIR,AbbVie,CHEMBL3391662,An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor,Chronic HCV genotype 1 infection,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2014,NA,NA
Viekira Pak,Ombitasvir; paritaprevir; dasabuvir; ritonavir,DASABUVIR,AbbVie,CHEMBL3137312,An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor,Chronic HCV genotype 1 infection,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2014,NA,NA
Viekira Pak,Ombitasvir; paritaprevir; dasabuvir; ritonavir,RITONAVIR,AbbVie,CHEMBL163,An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor,Chronic HCV genotype 1 infection,hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2014,"ENSG00000021461, ENSG00000160870, ENSG00000106258, ENSG00000160868",NA
Zerbaxa,Ceftolozane; tazobactam,CEFTOLOZANE,Cubist,CHEMBL2103872,A cephalosporin antibacterial plus a beta-lactamase inhibitor,Complicated intra-abdominal infections and complicated urinary tract infections,infection,EFO_0000544,Infectious,P,2014,NA,NA
Zerbaxa,Ceftolozane; tazobactam,TAZOBACTAM,Cubist,CHEMBL404,A cephalosporin antibacterial plus a beta-lactamase inhibitor,Complicated intra-abdominal infections and complicated urinary tract infections,infection,EFO_0000544,Infectious,P,2014,NA,NA
Rapivab,Peramivir,PERAMIVIR,BioCryst,CHEMBL3989402,Neuraminidase inhibitor,Influenza infection,influenza,EFO_0007328,Infectious,S,2014,NA,NA
Rapivab,Peramivir,PERAMIVIR,BioCryst,CHEMBL139367,Neuraminidase inhibitor,Influenza infection,influenza,EFO_0007328,Infectious,S,2014,NA,NA
Opdivo,Nivolumab,NIVOLUMAB,Bristol-Myers Squibb,CHEMBL2108738,PD1 inhibitor,Unresectable or metastatic melanoma,metastatic melanoma,EFO_0002617,Oncology,"P, O, B, A",2014,"ENSG00000188389, ENSG00000120217",TRUE
Savaysa,Edoxaban,EDOXABAN,Daiichi Sankyo,CHEMBL1269025,Factor Xa inhibitor,"Risk of stroke and systemic embolism in NVAF, and deep vein thrombosis",atrial fibrillation; deep vein thrombosis,EFO_0000275; EFO_0003907,Cardiovascular,S,2015,ENSG00000126218,TRUE
Cosentyx,Secukinumab,SECUKINUMAB,Novartis,CHEMBL1743068,IL-17A antagonist,"Plaque psoriasis, *psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.",psoriasis vulgaris,EFO_1001494,Dermatology,S,2015,ENSG00000112115,FALSE
Natpara,Parathyroid hormone,PARATHYROID HORMONE,NPS Pharma,CHEMBL2108078,Hormonal injection,Hypocalcaemia in patients with hypoparathyroidism,hypoparathyroidism; Hypocalcemia,EFO_0009451; HP_0002901,Endocrine,"S, O",2015,ENSG00000160801,TRUE
Ibrance,Palbociclib,PALBOCICLIB,Pfizer,CHEMBL189963,CDK4 and CDK6 inhibitor,"ER-positive, HER2-negative advanced breast cancer",HER2 negative breast carcinoma,EFO_0009780,Oncology,"P, B, A",2015,"ENSG00000135446, ENSG00000110092, ENSG00000105810",TRUE
Lenvima,Lenvatinib,LENVATINIB,Eisai,CHEMBL1289601,VEGFR inhibitor,Thyroid cancer,thyroid cancer,MONDO_0002108,Oncology,"P, O",2015,"ENSG00000037280, ENSG00000128052, ENSG00000102755",TRUE
Farydak,Panobinostat,PANOBINOSTAT,Novartis,CHEMBL483254,Histone deacetylase inhibitor,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O, A",2015,"ENSG00000100429, ENSG00000196591, ENSG00000163517, ENSG00000061273, ENSG00000068024, ENSG00000048052, ENSG00000116478, ENSG00000108840, ENSG00000094631, ENSG00000171720, ENSG00000147099",TRUE
Avycaz,Avibactam; ceftazidime,AVIBACTAM,Allergan,CHEMBL1689063,A beta-lactamase inhibitor and a cephalosporin,Complicated intra-abdominal infections and complicated urinary tract infections,infection,EFO_0000544,Infectious,P,2015,NA,NA
Avycaz,Avibactam; ceftazidime,CEFTAZIDIME,Allergan,CHEMBL44354,A beta-lactamase inhibitor and a cephalosporin,Complicated intra-abdominal infections and complicated urinary tract infections,infection,EFO_0000544,Infectious,P,2015,NA,NA
Cresemba,Isavuconazonium,ISAVUCONAZONIUM,Astellas,CHEMBL1183349,Azole antifungal,Antifungal,aspergillosis; mucormycosis,EFO_0007157; EFO_0007380,Infectious,"P, O",2015,NA,NA
Unituxin,Dinutuximab,DINUTUXIMAB,United Therapeutics,CHEMBL3137342,GD2-binding mAb,Neuroblastoma,neuroblastoma,EFO_0000621,Oncology,"P, O",2015,NA,NA
Cholbam,Cholic acid,CHOLIC ACID,Retrophin,CHEMBL205596,A primary bile acid,Bile acid synthesis disorders and peroxisomal disorders,peroxisomal disease; Disorder of bile acid synthesis,MONDO_0019053; Orphanet_79168,Metabolic,"P, O",2015,NA,NA
Corlanor,Ivabradine,IVABRADINE,Amgen,CHEMBL471737,Hyperpolarization-activated cyclic nucleotide-gated channel blocker,Chronic heart failure,congestive heart failure,EFO_0000373,Cardiovascular,P,2015,ENSG00000138622,TRUE
Kybella,Deoxycholic acid,DEOXYCHOLIC ACID,Kythera,CHEMBL406393,Cytolytic drug,Fat below the chin,body fat distribution,EFO_0004341,Other,S,2015,NA,NA
Viberzi,Eluxadoline,ELUXADOLINE,Allergan,CHEMBL2159122,Mu-opioid receptor agonist,Irritable bowel syndrome,irritable bowel syndrome,EFO_0000555,Gastrointestinal,P,2015,ENSG00000112038,FALSE
Kengreal,Cangrelor,CANGRELOR,Medicines Company,CHEMBL334966,P2Y12 platelet inhibitor,"Myocardial infarction, repeat coronary revascularization, and stent thrombosis",myocardial infarction,EFO_0000612,Cardiovascular,S,2015,ENSG00000169313,FALSE
Orkambi,Ivacaftor; lumacaftor,IVACAFTOR,Vertex,CHEMBL2010601,CFTR potentiator plus CFTR corrector,Cystic fibrosis in patients with homozygous DF508 CFTR mutation,cystic fibrosis,MONDO_0009061,Other,"P, O, B",2015,ENSG00000001626,TRUE
Orkambi,Ivacaftor; lumacaftor,LUMACAFTOR,Vertex,CHEMBL2103870,CFTR potentiator plus CFTR corrector,Cystic fibrosis in patients with homozygous DF508 CFTR mutation,cystic fibrosis,MONDO_0009061,Other,"P, O, B",2015,ENSG00000001626,TRUE
Entresto,Sacubitril; valsartan,SACUBITRIL,Novartis,CHEMBL3137301,A neprilysin inhibitor plus an angiotensin II receptor blocker,Chronic heart failure,congestive heart failure,EFO_0000373,Cardiovascular,P,2015,ENSG00000196549,TRUE
Entresto,Sacubitril; valsartan,VALSARTAN,Novartis,CHEMBL1069,A neprilysin inhibitor plus an angiotensin II receptor blocker,Chronic heart failure,congestive heart failure,EFO_0000373,Cardiovascular,P,2015,ENSG00000144891,TRUE
Rexulti,Brexpiprazole,BREXPIPRAZOLE,Otsuka,CHEMBL2105760,Atypical antipsychotic,MDD and schizophrenia,major depressive disorder; schizophrenia,MONDO_0002009; MONDO_0005090,Mental health,S,2015,"ENSG00000149295, ENSG00000178394, ENSG00000102468",TRUE
Praluent,Alirocumab,ALIROCUMAB,Sanofi,CHEMBL2109540,PCSK9 inhibitor,LDL lowering,LDL cholesterol change measurement,EFO_0007804,Cardiovascular,P,2015,ENSG00000169174,TRUE
Odomzo,Sonidegib,SONIDEGIB,Novartis,CHEMBL2105737,Smoothened inhibitor,Basal cell carcinoma,basal cell carcinoma,EFO_0004193,Oncology,S,2015,ENSG00000128602,TRUE
Daklinza,Daclatasvir,DACLATASVIR,Bristol-Myers Squibb,CHEMBL2023898,NS5A inhibitor,HCV,hepatitis C virus infection,EFO_0003047,Infectious,P,2015,NA,NA
Addyi,Flibanserin,FLIBANSERIN,Sprout,CHEMBL231068,Serotonin receptor modulator,Hypoactive sexual desire disorder,sexual dysfunction,EFO_0004714,Other,S,2015,"ENSG00000178394, ENSG00000102468, ENSG00000069696",FALSE
Repatha,Evolocumab,EVOLOCUMAB,Amgen,CHEMBL2364655,PCSK9 inhibitor,LDL lowering,LDL cholesterol change measurement,EFO_0007804,Cardiovascular,"S, O",2015,ENSG00000169174,TRUE
Varubi,Rolapitant,ROLAPITANT,Tesaro,CHEMBL3707331,Neurokinin 1 receptor antagonist,Nausea and vomiting associated with chemotherapy,Chemotherapy-induced nausea and vomiting,EFO_0006911,Other,S,2015,ENSG00000115353,FALSE
Xuriden,Uridine,URIDINE,Wellstat,CHEMBL100259,Pyrimidine analogue,Hereditary orotic aciduria,Hereditary orotic aciduria,Orphanet_30,Metabolic,"P, O, B",2015,NA,NA
Vraylar,Cariprazine,CARIPRAZINE,Forest,CHEMBL2028019,Atypical antipsychotic,Schizophrenia and bipolar 1 disorder,Schizophrenia; bipolar disorder,MONDO_0005090; MONDO_0004985,Mental health,S,2015,"ENSG00000151577, ENSG00000149295",TRUE
Lonsurf,Tipiracil; trifluridine,TIPIRACIL,Taiho,CHEMBL235668,Thymidine phosphorylase inhibitor plus a nucleoside metabolic inhibitor,Colorectal cancer,colorectal cancer,EFO_0005842,Oncology,S,2015,ENSG00000025708,TRUE
Lonsurf,Tipiracil; trifluridine,TRIFLURIDINE,Taiho,CHEMBL1129,Thymidine phosphorylase inhibitor plus a nucleoside metabolic inhibitor,Colorectal cancer,colorectal cancer,EFO_0005842,Oncology,S,2015,ENSG00000176890,TRUE
Tresiba,Insulin degludec,INSULIN DEGLUDEC,Novo Nordisk,CHEMBL2107869,Long-acting insulin,Diabetes,diabetes mellitus,EFO_0000400,Metabolic,S,2015,ENSG00000171105,TRUE
Aristada,Aripiprazole lauroxil,ARIPIPRAZOLE LAUROXIL,Alkermes,CHEMBL2219425,Extended release atypical antipsychotic,Schizophrenia,schizophrenia,MONDO_0005090,Mental health,S,2015,"ENSG00000102468, ENSG00000178394, ENSG00000149295",TRUE
Praxbind,Idarucizumab,IDARUCIZUMAB,Boehringer Ingelheim,CHEMBL3544996,Dabigatran-binding mAb fragment,Reversal of anticoagulant effects of dabigatran,response to anticoagulant,GO_0061476,Other,"P, O, B, A",2015,NA,NA
Veltassa,Patiromer sorbitex,PATIROMER SORBITEX,Relypsa,CHEMBL2107840,Potassium binder,Hyperkalaemia,Hyperkalemia,HP_0002153,Other,S,2015,NA,NA
Strensiq,Asfotase alfa,ASFOTASE ALFA,Alexion,CHEMBL2108311,Alkaline phosphatase,Hypophosphatasia,hypophosphatasia,MONDO_0018570,Other,"P, O, B",2015,ENSG00000162551,TRUE
Yondelis,Trabectedin,TRABECTEDIN,Johnson & Johnson,CHEMBL450449,Alkylating drug,Liposarcoma or leiomyosarcoma,liposarcoma; leiomyosarcoma,EFO_0000569; EFO_0000564,Oncology,"P, O",2015,NA,NA
Nucala,Mepolizumab,MEPOLIZUMAB,GlaxoSmithKline,CHEMBL2108429,IL-5 antagonist,Severe asthma,Status Asthmaticus,EFO_0008590,Respiratory,S,2015,ENSG00000113525,TRUE
Genvoya,Elvitegravir; cobicistat; emtricitabine; tenofovir,ELVITEGRAVIR,Gilead,CHEMBL204656,An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors,HIV,HIV infection,EFO_0000764,Infectious,S,2015,NA,NA
Genvoya,Elvitegravir; cobicistat; emtricitabine; tenofovir,COBICISTAT,Gilead,CHEMBL2095208,An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors,HIV,HIV infection,EFO_0000764,Infectious,S,2015,"ENSG00000160870, ENSG00000106258, ENSG00000160868, ENSG00000021461",NA
Genvoya,Elvitegravir; cobicistat; emtricitabine; tenofovir,EMTRICITABINE,Gilead,CHEMBL885,An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors,HIV,HIV infection,EFO_0000764,Infectious,S,2015,NA,NA
Genvoya,Elvitegravir; cobicistat; emtricitabine; tenofovir,TENOFOVIR,Gilead,CHEMBL483,An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors,HIV,HIV infection,EFO_0000764,Infectious,S,2015,NA,NA
Cotellic,Cobimetinib,COBIMETINIB,Genentech,CHEMBL2146883,MEK inhibitor,Melanoma with BRAFV600E/K mutations,melanoma,EFO_0000756,Oncology,"P, O",2015,"ENSG00000126934, ENSG00000169032",TRUE
Tagrisso,Osimertinib,OSIMERTINIB,AstraZeneca,CHEMBL3353410,EGFR inhibitor,NSCLC with EGFRT790M mutations,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2015,ENSG00000146648,TRUE
Darzalex,Daratumumab,DARATUMUMAB,Johnson & Johnson,CHEMBL1743007,CD38-directed mAb,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O, B, A",2015,ENSG00000004468,TRUE
Ninlaro,Ixazomib,IXAZOMIB,Takeda,CHEMBL2141296,Oral proteasome inhibitor,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O",2015,"ENSG00000165916, ENSG00000240065, ENSG00000159377, ENSG00000108671, ENSG00000100804, ENSG00000161057, ENSG00000154611, ENSG00000159352, ENSG00000100902, ENSG00000013275, ENSG00000173692, ENSG00000101182, ENSG00000103035, ENSG00000129084, ENSG00000142507, ENSG00000222028, ENSG00000197170, ENSG00000175166, ENSG00000205220, ENSG00000100764, ENSG00000277791, ENSG00000136930, ENSG00000099341, ENSG00000163636, ENSG00000185627, ENSG00000127922, ENSG00000115233, ENSG00000087191, ENSG00000108344, ENSG00000204264, ENSG00000100519, ENSG00000100567, ENSG00000143106, ENSG00000126067, ENSG00000130706, ENSG00000106588, ENSG00000008018, ENSG00000041357",TRUE
Portrazza,Necitumumab,NECITUMUMAB,Eli Lilly,CHEMBL1743047,EGFR antagonist,NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"S, O",2015,ENSG00000146648,TRUE
Empliciti,Elotuzumab,ELOTUZUMAB,Bristol-Myers Squibb,CHEMBL1743010,SLAMF7-directed mAb,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"P, O, B",2015,ENSG00000026751,TRUE
Kanuma,Sebelipase alfa,SEBELIPASE ALFA,Alexion,CHEMBL3039537,Enzyme replacement therapy,LAL deficiency,lysosomal acid lipase deficiency,MONDO_0010204,Metabolic,"P, O, B",2015,ENSG00000107798,TRUE
Alecensa,Alectinib,ALECTINIB,Roche,CHEMBL1738797,ALK inhibitor,NSCLC,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O, B, A",2015,"ENSG00000171094, ENSG00000143924, ENSG00000165731",TRUE
Bridion,Sugammadex,SUGAMMADEX,Merck & Co.,CHEMBL2111107,A modified gamma cyclodextrin,Reversal of neuromuscular blockade during surgery,neuromuscular disease,EFO_1001902,Other,P,2015,NA,NA
Uptravi,Selexipag,SELEXIPAG,Actelion,CHEMBL238804,Prostacyclin receptor agonist,Pulmonary arterial hypertension,pulmonary arterial hypertension,EFO_0001361,Cardiovascular,"S, O",2015,ENSG00000160013,FALSE
Zurampic,Lesinurad,LESINURAD,AstraZeneca,CHEMBL2105720,URAT1 inhibitor,Gout,gout,EFO_0004274,Other,S,2015,ENSG00000197891,TRUE
Nesina,Alogliptin,ALOGLIPTIN,Takeda,CHEMBL376359,DPP4 inhibitor,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Metabolic,S,2013,ENSG00000197635,TRUE
Kynamro,Mipomersen,MIPOMERSEN,Genzyme,CHEMBL2219536,Oligonucleotide inhibitor of apolipoprotein B100 synthesis,Homozygous familial hypercholesterolaemia,homozygous familial hypercholesterolemia,MONDO_0018328,Cardiovascular,"S, O",2013,ENSG00000084674,TRUE
Pomalyst,Pomalidomide,POMALIDOMIDE,Celgene,CHEMBL43452,Immunomodulatory antineoplastic agent,Multiple myeloma,multiple myeloma,EFO_0001378,Oncology,"S, O",2013,"ENSG00000167986, ENSG00000139842, ENSG00000113851, ENSG00000100387",TRUE
Kadcyla,Ado-trastuzumab emtansine,TRASTUZUMAB EMTANSINE,Genentech,CHEMBL1743082,HER2-targeted antibody and microtubule inhibitor conjugate,HER2-positive metastatic breast cancer,HER2 Positive Breast Carcinoma,EFO_1000294,Oncology,P,2013,"ENSG00000167553, ENSG00000196230, ENSG00000137285, ENSG00000123416, ENSG00000176014, ENSG00000137267, ENSG00000101162, ENSG00000258947, ENSG00000261456, ENSG00000188229, ENSG00000104833, ENSG00000127824, ENSG00000198033, ENSG00000167552, ENSG00000152086, ENSG00000141736",TRUE
Osphena,Ospemifene,OSPEMIFENE,Shionogi,CHEMBL2105395,Oestrogen receptor modulator,Moderate to severe dyspareunia due to menopause,Dyspareunia; menopause,HP_0030016; EFO_0003922,Reproductive,S,2013,"ENSG00000140009, ENSG00000091831",TRUE
Lymphoseek kit,Technetium TC 99m tilmanocept,TECHNETIUM TC 99M TILMANOCEPT,Navidea,CHEMBL2108726,Radioactive diagnostic agent,Lymphatic mapping in patients with breast cancer or melanoma,breast cancer; melanoma,MONDO_0007254; EFO_0000756,Imaging,S,2013,ENSG00000260314,FALSE
Dotarem,Gadoterate meglumine,GADOTERATE MEGLUMINE,Guerbet,CHEMBL2219415,Gadolinium-based contrast agent,Contrast agent to visualize disruption of the blood-brain barrier,NA,NA,Imaging,P,2013,NA,NA
Tecfidera,Dimethyl fumarate,DIMETHYL FUMARATE,Biogen Idec,CHEMBL2107333,MOA unknown; activates NRF2 pathway,Relapsing forms of multiple sclerosis,relapsing-remitting multiple sclerosis,EFO_0003929,Neurological,S,2013,ENSG00000079999,TRUE
Invokana,Canagliflozin,CANAGLIFLOZIN,Janssen,CHEMBL4594217,SGLT2 inhibitor,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Metabolic,S,2013,ENSG00000140675,TRUE
Invokana,Canagliflozin,CANAGLIFLOZIN,Janssen,CHEMBL2048484,SGLT2 inhibitor,Type 2 diabetes,type 2 diabetes mellitus,MONDO_0005148,Metabolic,S,2013,ENSG00000140675,TRUE
Breo Ellipta,Fluticasone; vilanterol,FLUTICASONE,GSK,CHEMBL1473,Corticosteroid plus LABA,Chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO_0000341,Respiratory,S,2013,ENSG00000113580,TRUE
Breo Ellipta,Fluticasone; vilanterol,VILANTEROL,GSK,CHEMBL1198857,Corticosteroid plus LABA,Chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO_0000341,Respiratory,S,2013,ENSG00000169252,TRUE
Xofigo,Radium RA 223 dichloride,RADIUM RA 223 DICHLORIDE,Bayer,CHEMBL2107816,Alpha particle-emitting radioactive therapeutic,Castration-resistant prostate cancer,prostate cancer,MONDO_0008315,Imaging,P,2013,NA,NA
Tafinlar,Dabrafenib,DABRAFENIB,GSK,CHEMBL2028663,"Kinase inhibitor with activity against BRAFV600E, BRAFV600K, BRAFV600D, wild-type BRAF and other kinases",Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test,metastatic melanoma,EFO_0002617,Oncology,"S, O",2013,ENSG00000157764,TRUE
Mekinist,Trametinib,TRAMETINIB,GSK,CHEMBL2103875,MEK1 and MEK2 kinase inhibitor,Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test,metastatic melanoma,EFO_0002617,Oncology,"S, O",2013,"ENSG00000169032, ENSG00000126934",TRUE
Gilotrif,Afatinib,AFATINIB,Boehringer Ingelheim,CHEMBL1173655,"EGFR (ERBB1), HER2 (ERBB2), and HER4 (ERRB4) kinase inhibitor",First-line treatment of patients with metastatic NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test,non-small cell lung carcinoma,EFO_0003060,Oncology,"P, O",2013,"ENSG00000141736, ENSG00000146648, ENSG00000178568",TRUE
Tivicay,Dolutegravir,DOLUTEGRAVIR,ViiV,CHEMBL1229211,HIV1 integrase strand transfer inhibitor,"HIV1 infection in adults and children, in combination with other antiretroviral agents",HIV infection,EFO_0000764,Infectious,P,2013,NA,NA
Brintellix,Vortioxetine,VORTIOXETINE,Takeda,CHEMBL2104993,Serotonin reuptake inhibitor,Major depressive disorder,major depressive disorder,MONDO_0002009,Mental health,S,2013,"ENSG00000178394, ENSG00000108576, ENSG00000166736",TRUE
Duavee,Bazedoxifene acetate; oestrogens,BAZEDOXIFENE ACETATE,Pfizer,CHEMBL2106615,Conjugated oestrogens with an oestrogen receptor modulator,Moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis,menopause; postmenopausal osteoporosis,EFO_0003922; EFO_0003854,Other,S,2013,"ENSG00000091831, ENSG00000140009",TRUE
Duavee,Bazedoxifene acetate; oestrogens,"ESTROGENS, CONJUGATED",Pfizer,CHEMBL1201649,Conjugated oestrogens with an oestrogen receptor modulator,Moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis,menopause; postmenopausal osteoporosis,EFO_0003922; EFO_0003854,Other,S,2013,"ENSG00000140009, ENSG00000091831",TRUE
Adempas,Riociguat,RIOCIGUAT,Bayer,CHEMBL2107834,Soluble guanylyl cyclase stimulator,Persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension,pulmonary arterial hypertension,EFO_0001361,Cardiovascular,"P, O",2013,"ENSG00000123201, ENSG00000164116, ENSG00000061918, ENSG00000152402",TRUE
Opsumit,Macitentan,MACITENTAN,Actelion,CHEMBL2103873,Endothelin receptor antagonist,Pulmonary arterial hypertension,pulmonary arterial hypertension,EFO_0001361,Cardiovascular,"S, O",2013,"ENSG00000136160, ENSG00000151617",TRUE
Vizamyl,Flutemetamol F-18,FLUTEMETAMOL F-18,GE Healthcare,CHEMBL2042122,Radioactive diagnostic agent,PET imaging of the brain to estimate beta-amyloid neuritic plaque density in patients who are being evaluated for Alzheimer's disease,neuritic plaque measurement; Alzheimer disease,EFO_0006798; MONDO_0004975,Imaging,S,2013,ENSG00000142192,TRUE
Gazyva,Obinutuzumab,OBINUTUZUMAB,Genentech,CHEMBL1743048,Humanized CD20-specific monoclonal antibody,Previously untreated chronic lymphocytic leukaemia,chronic lymphocytic leukemia,EFO_0000095,Oncology,"P, O, B",2013,ENSG00000156738,TRUE
Aptiom,Eslicarbazepine,ESLICARBAZEPINE,Sunovion,CHEMBL315985,"MOA unknown, but thought to involve voltage-gated sodium channels",Partial-onset seizures,Seizure,HP_0001250,Neurological,S,2013,"ENSG00000168356, ENSG00000169432, ENSG00000144285, ENSG00000007314, ENSG00000136546, ENSG00000185313, ENSG00000136531, ENSG00000183873, ENSG00000196876, ENSG00000153253",TRUE
Imbruvica,Ibrutinib,IBRUTINIB,Pharmacyclics,CHEMBL1873475,Bruton's tyrosine kinase inhibitor,Mantle cell lymphoma,Mantle cell lymphoma,EFO_1001469,Oncology,"P, O, B",2013,ENSG00000010671,TRUE
Luzu,Luliconazole,LULICONAZOLE,Medicis,CHEMBL2105689,Azole antifungal,"Interdigital tinea pedis, tinea cruris and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum",tinea,EFO_0007510,"Dermatology, infectious",S,2013,NA,NA
Olysio,Simeprevir,SIMEPREVIR,Janssen,CHEMBL501849,HCV NS3/4A protease inhibitor,"Chronic HCV infection, as a component of a combination antiviral treatment regimen",hepatitis C virus infection,EFO_0003047,Infectious,P,2013,NA,NA
Sovaldi,Sofosbuvir,SOFOSBUVIR,Gilead,CHEMBL1259059,HCV nucleotide analogue NS5B polymerase inhibitor,"Chronic HCV infection, as a component of a combination antiviral treatment regimen",hepatitis C virus infection,EFO_0003047,Infectious,"P, B",2013,NA,NA
Anoro Ellipta,Umeclidinium; vilanterol,UMECLIDINIUM,GSK,CHEMBL1187833,Anticholinergic and a LABA,Chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO_0000341,Respiratory,S,2013,ENSG00000133019,TRUE
Anoro Ellipta,Umeclidinium; vilanterol,VILANTEROL,GSK,CHEMBL1198857,Anticholinergic and a LABA,Chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO_0000341,Respiratory,S,2013,ENSG00000169252,TRUE